Author: "Yohan Nguyen" / Publication Year Range: Last 10 years - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Yohan Nguyen"' showing total 38 results

Start Over Author "Yohan Nguyen" Publication Year Range Last 10 years

38 results on '"Yohan Nguyen"'

1. Structures and Functions of Viral 5′ Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections

Author: Marie Glenet, Laetitia Heng, Domitille Callon, Anne-Laure Lebreil, Paul-Antoine Gretteau, Yohan Nguyen, Fatma Berri, and Laurent Andreoletti
Subjects: group-B enterovirus, RNA domain-I, viral ribonucleoprotein complexes, enterovirus replication, 5′ terminally deleted viral forms, antiviral innate immune response, Microbiology, QR1-502
Abstract: Group-B enteroviruses (EV-B) are ubiquitous naked single-stranded positive RNA viral pathogens that are responsible for common acute or persistent human infections. Their genome is composed in the 5′ end by a non-coding region, which is crucial for the initiation of the viral replication and translation processes. RNA domain-I secondary structures can interact with viral or cellular proteins to form viral ribonucleoprotein (RNP) complexes regulating viral genomic replication, whereas RNA domains-II to -VII (internal ribosome entry site, IRES) are known to interact with cellular ribosomal subunits to initiate the viral translation process. Natural 5′ terminally deleted viral forms lacking some genomic RNA domain-I secondary structures have been described in EV-B induced murine or human infections. Recent in vitro studies have evidenced that the loss of some viral RNP complexes in the RNA domain-I can modulate the viral replication and infectivity levels in EV-B infections. Moreover, the disruption of secondary structures of RNA domain-I could impair viral RNA sensing by RIG-I (Retinoic acid inducible gene I) or MDA5 (melanoma differentiation-associated protein 5) receptors, a way to overcome antiviral innate immune response. Overall, natural 5′ terminally deleted viral genomes resulting in the loss of various structures in the RNA domain-I could be major key players of host–cell interactions driving the development of acute or persistent EV-B infections.
Published: 2020
Full Text: View/download PDF

2. Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues

Author: Alexis Bouin, Yohan Nguyen, Michel Wehbe, Fanny Renois, Paul Fornes, Firouze Bani-Sadr, Damien Metz, and Laurent Andreoletti
Subjects: idiopathic dilated cardiomyopathy, coxsackievirus B3, 5′ terminally deleted populations, viruses, endomyocardial, heart, Medicine, Infectious and parasitic diseases, RC109-216
Abstract: We performed deep sequencing analysis of the enterovirus 5′ noncoding region in cardiac biopsies from a patient with dilated cardiomyopathy. Results displayed a mix of deleted and full-length coxsackievirus B3, characterized by a low viral RNA load (8.102 copies/μg of nucleic acids) and a low viral RNA positive-sense to RNA negative-sense ratio of 4.8.
Published: 2016
Full Text: View/download PDF

3. Eosinophilia during Hantavirus infection: a cohort study

Author: Laure-Anne Pannet, Amélie Servettaz, Maxime Hentzien, Yohan Nguyen, Stéphanie Mestrallet, Firouzé Bani-Sadr, Laurent Andreoletti, Delphine Lebrun, Messaline Bermejo, Jean-Marc Reynes, Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Hospitalier de Charleville-Mezières, Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Reims Champagne-Ardenne (URCA), Environnement et Risques infectieux - Environment and Infectious Risks (ERI), Institut Pasteur [Paris] (IP), and Centre National de Référence Hantavirus / National Reference Center Hantavirus (CNR )
Subjects: Microbiology (medical), Orthohantavirus, Hantavirus Infections, Puumala virus, MESH: Eosinophilia, Cohort Studies, MESH: Hemorrhagic Fever with Renal Syndrome, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, White blood cell, MESH: C-Reactive Protein, Nephropathia epidemica, Nephropathia Epidemica, Medicine, Eosinophilia, Humans, haemorrhagic fever with renal syndrome, MESH: Cohort Studies, Hantavirus, MESH: Humans, General Immunology and Microbiology, biology, business.industry, MESH: Hantavirus, MESH: Puumala virus, virus diseases, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, General Medicine, Eosinophil, respiratory system, biology.organism_classification, medicine.disease, Infectious Diseases, medicine.anatomical_structure, C-Reactive Protein, Hemorrhagic Fever with Renal Syndrome, Immunology, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Absolute neutrophil count, medicine.symptom, business, Hantavirus Infection, eosinophilia, MESH: Hantavirus Infections
Abstract: International audience; BackgroundThere are emerging eosinophil-related considerations concerning viral infections. The role of eosinophils has poorly been evaluated during Hantavirus infection.MethodsThe aim of this study was to determine the prevalence of eosinophilia (defined as an eosinophil count above 500 cells/mm3) during haemorrhagic fever with renal syndrome (HFRS) in a large cohort of patients, and to identify factors associated with eosinophilia.ResultsAmong 387 patients hospitalized for HFRS, 98 (25.3%) had eosinophilia. By univariate analysis, eosinophilia was significantly associated with more severe thrombocytopenia, high C-reactive protein level, white blood cell count and neutrophil count and lower nephrotoxic drug intake. As there was a collinearity between white blood cell count and C-reactive protein level, only C-reactive protein level with platelet count and nephrotoxic drug intake were entered in the multivariable analysis. Elevated C-reactive protein concentrations remained independently associated with eosinophilia.ConclusionEosinophilia during HFRS affects one quarter of patients, and supports the role of eosinophils in antiviral immunity against hantavirus infection.
Published: 2022

4. Surfaces and Air Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 Using High-Flow Nasal Oxygenation or Assisted Mechanical Ventilation in Intensive Care Unit Rooms of Patients With Coronavirus Disease 2019

Author: Laurent Andreoletti, Fatma Berri, Vincent Greux, Anne-Laure Lebreil, Yohan Nguyen, Antoine Huguenin, Bruno Mourvillier, Marie Glenet, and Odile Bajolet
Subjects: medicine.medical_treatment, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Air Microbiology, medicine.disease_cause, 03 medical and health sciences, 0302 clinical medicine, Patients' Rooms, Immunology and Allergy, Medicine, Infection control, Humans, 030212 general & internal medicine, Aerosolization, 030304 developmental biology, Mechanical ventilation, 0303 health sciences, business.industry, SARS-CoV-2, COVID-19, Oxygenation, Contamination, Respiration, Artificial, 3. Good health, Transmission-based precautions, Intensive Care Units, Infectious Diseases, Anesthesia, RNA, Viral, business, Nasal cannula
Abstract: Background Understanding patterns of environmental contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for infection prevention policies. Methods We screened surfaces and air samples from single-bed intensive-care unit rooms of adult patients with coronavirus disease 2019 (COVID-19) for SARS-CoV-2 RNA and viable viruses. Results We evidenced viral RNA environmental contamination in 76% of 100 surfaces samples and in 30% of 40 air samples without any viable virus detection by cell culture assays. No significant differences of viral RNA levels on surfaces and in ambient air were observed between rooms of patients with assisted mechanical ventilation and those of patients with a high-flow nasal cannula system. Using an original experimental SARS-CoV-2 infection model of surfaces, we determined that infectious viruses may have been present on benches within 15 hours before the time of sampling in patient rooms. Conclusions We observed that SARS-CoV-2 environmental contamination around patients with COVID-19 hospitalized in single-bed ICU rooms was extensive and that a high-flow nasal cannula system did not generate more viral aerosolization than a mechanical ventilation system in patients with COVID-19. Despite an absence of SARS-CoV-2 viable particles in study samples, our experimental model confirmed the need to apply strict environmental disinfection procedures and classic standard and droplet precautions in ICU wards.
Published: 2021

5. No more than meets the eye

Author: Adrien Henry, Louis-Philippe Dormegnie, Jean-Hugues Salmon, Yohan Nguyen, Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], and Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: 030203 arthritis & rheumatology, business.industry, [SDV]Life Sciences [q-bio], Eye, World Wide Web, 03 medical and health sciences, 0302 clinical medicine, Text mining, 030221 ophthalmology & optometry, Internal Medicine, Medicine, Humans, business, ComputingMilieux_MISCELLANEOUS
Abstract: International audience
Published: 2021

6. Case Report: Could Artemisinin-Based Combination Therapy Prevent Occupational Malaria following Blood Exposure?

Author: Sylvie Touche, Anne Catherine Delavelle, Yohan Nguyen, Antoine Huguenin, Geoffrey Minard, Morgane Bonnet, and Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: Adult, medicine.medical_specialty, Combination therapy, 030231 tropical medicine, Parasitemia, Serology, 03 medical and health sciences, Antimalarials, 0302 clinical medicine, Blood exposure, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Virology, Internal medicine, parasitic diseases, medicine, Humans, 030212 general & internal medicine, Artemisinin, Malaria, Falciparum, Needlestick Injuries, biology, business.industry, Artemether, Lumefantrine Drug Combination, Plasmodium falciparum, Articles, biology.organism_classification, medicine.disease, 3. Good health, Infectious Diseases, Blood smear, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Parasitology, Female, business, Post-Exposure Prophylaxis, Malaria, medicine.drug
Abstract: International audience; Postexposure prophylaxis using artemisinin-based combination therapy (ACT) was prescribed to a malarianaive nurse who experienced an injury with a hollow needle previously used on a patient admitted for severe imported Plasmodium falciparum malaria (blood parasitemia 10.8%). Artemether-lumefantrine, four tablets twice daily for 3 days, was started 12 hours after exposure, and no side effects were reported. During the six following months, she only developed one episode of fever that was associated with pyelonephritis. Biological follow-up, based on blood smears, molecular biology, and serology, did not evidence P. falciparum malaria. This case suggests that ACT can prevent occupational P. falciparum malaria following needle-stick injury. We found evidence of only one other unpublished similar case where a Turkish resident doctor did not develop malaria after postexposure prophylaxis using ACT. Such a prophylaxis could be prescribed not only in case of occupational exposure to Plasmodium spp. in nonvector-borne laboratory-acquired infections but also following blood exposure in healthcare setting.
Published: 2020

7. Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study

Author: Madeline Pascard, M. Hentzien, Lukshe Kanagaratnam, Firouzé Bani-Sadr, Yohan Nguyen, Laurent Andreoletti, Damien Jolly, Amélie Servettaz, Centre Hospitalier Universitaire de Reims (CHU Reims), Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509 (IRMAIC), Université de Reims Champagne-Ardenne (URCA), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), and Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: 0301 basic medicine, Male, Multivariate analysis, [SDV]Life Sciences [q-bio], law.invention, 0302 clinical medicine, law, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Adrenal Cortex Hormones, Corticosteroid, Pharmacology (medical), 030212 general & internal medicine, Hospital Mortality, ComputingMilieux_MISCELLANEOUS, Aged, 80 and over, Hazard ratio, General Medicine, Early warning score, Intensive care unit, 3. Good health, Infectious Diseases, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Female, Coronavirus Infections, Microbiology (medical), medicine.medical_specialty, medicine.drug_class, 030106 microbiology, Pneumonia, Viral, Lower risk, Article, 03 medical and health sciences, Betacoronavirus, Internal medicine, medicine, Humans, COVID-19 pneumonia, Pandemics, Aged, business.industry, SARS-CoV-2, COVID-19, medicine.disease, Confidence interval, respiratory tract diseases, COVID-19 Drug Treatment, Pneumonia, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract: Highlights • Severe COVID-19 patients present overwhelming inflammatory reactions leading to lung injury. • Corticosteroids may beneficially modulate the host immune response to COVID-19 pneumonia. • Before–after study evaluating the effect of corticosteroid addition to COVID-19 pneumonia treatment on hospital mortality. • In multivariate analysis, the ‘after’ period was associated with an adjusted lower risk of death (aHR = 0.47; P = 0.04). • ‘After’ period was also associated with lower risk of ICU admission or death before ICU admission (aHR = 0.37; P < 0.001)., Anti-inflammatory drugs such as corticosteroids may beneficially modulate the host inflammatory response to coronavirus disease 2019 (COVID-19) pneumonia. The aim of this study was to evaluate the impact of addition of corticosteroids to the hospital protocol for treatment of suspected or confirmed COVID-19 pneumonia on rates of death or intensive care unit (ICU) admission. A before–after study was performed to evaluate the effect of addition of corticosteroids to our institution's COVID-19 treatment protocol on hospital mortality. A total of 257 patients with a COVID-19 diagnosis were included in this study between 3 March 2020 and 14 April 2020. As corticosteroids were widely used after 27 March 2020, two periods were considered for the purposes of this study: the ‘before’ period from 3–20 March 2020 (n = 85); and the ‘after’ period from 26 March–14 April 2020 (n = 172). The ‘after’ period was associated with a lower risk of death [adjusted hazard ratio (aHR) = 0.47, 95% confidence interval (CI) 0.23–0.97; P = 0.04] and a lower risk of ICU admission or of death before ICU admission (aHR = 0.37, 95% CI 0.21–0.64; P = 0.0005) by multivariate analysis adjusted for age, National Early Warning score and institutionalisation status. In conclusion, addition of corticosteroids to our institution's COVID-19 treatment protocol was associated with a significant reduction in hospital mortality in the ‘after’ period.
Published: 2020

8. Structures and Functions of Viral 5’ Non-Coding Genomic RNA Domain-I in Enterovirus-B Infections

Author: Paul-Antoine Gretteau, Laurent Andreoletti, Domitille Callon, Yohan Nguyen, Marie Glenet, Fatma Berri, Anne-Laure Lebreil, and Laetitia Heng
Subjects: viruses, Computational biology, Biology, Enterovirus B, Genomic rna, virology, Coding (social sciences), Domain (software engineering)
Abstract: Group-B enteroviruses (EV-B) are ubiquitous naked single-stranded positive RNA viral pathogens that are responsible for common acute or persistent human infections. Their genome is composed in the 5'end by a non-coding region, which is crucial for the initiation of the viral replication and translation processes. RNA domain-I secondary structures can interact with viral or cellular proteins to form viral ribonucleoprotein (RNP) complexes regulating viral genomic replication, whereas RNA domains-II to -VII (IRES) are known to interact with cellular ribosomal subunits to initiate the viral translation process. Natural 5’ terminally deleted viral forms lacking some genomic RNA domain-I secondary structures have been described in EV-B induced murine or human infections. Recent in vitro studies have evidenced that the loss of some viral RNP complexes in the RNA domain-I can modulate the viral replication and infectivity levels in EV-B infections. Moreover, the disruption of secondary structures of RNA domain-I could impair viral RNA sensing by RIG-I or MDA5 receptors, a way to overcome antiviral innate immune response. Overall, natural 5′ terminally deleted viral genomes resulting in the loss of various structures in the RNA domain-I could be major key players of host-cell interactions driving the development of acute or persistent EV-B infections.
Published: 2020

9. Vasculitides and glomerulonephritis associated with Staphylocococcus aureus infective endocarditis: cases reports and mini-review of the literature

Author: Gautier Julien, Firouzé Bani-Sadr, Olivia Beaudoux, Ambre Hittinger-Roux, Aurélie Brunet, Amélie Servettaz, Yohan Nguyen, Amandine Cros, Hôpital universitaire Robert Debré [Reims], Hôpital Maison Blanche, and Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: Adult, Male, Pathology, medicine.medical_specialty, Staphylococcus aureus, medicine.drug_class, Antibiotics, 030204 cardiovascular system & hematology, medicine.disease_cause, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, vasculitis, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Biopsy, Membranoproliferative glomerulonephritis, medicine, Humans, 030212 general & internal medicine, Review Articles, Anti-neutrophil cytoplasmic antibody, Aged, medicine.diagnostic_test, business.industry, infective endocarditis, Glomerulonephritis, General Medicine, Endocarditis, Bacterial, Staphylococcal Infections, medicine.disease, 3. Good health, Anti-Bacterial Agents, Infective endocarditis, Vasculitis, business, glomerulonephritis
Abstract: We reported two cases of Staphylococcus aureus Infective Endocarditis associated with vasculitides and glomerulonephritis respectively, before conducting an online search of previously published similar cases reports. Twenty five references were selected: 15 cases of glomerulonephritis; 2 cases of vasculitis and 8 cases involving both glomerulonephritis and vasculitis. Vasculitides and glomerulonephritis associated with Staphylococcus aureus definite Infective Endocarditis have been reported since 1976. All cases except one described clinical symptoms occurring before or during initial antibiotics treatment. Except kidney, organs that were more frequently affected by vasculitis process were skin, gastrointestinal tract and peripheral nerve and the vessels involved were small to medium size vessels. When antineutrophil cytoplasmic antibodies were evidenced (6 out of the 25 cases (24%)), kidney was the most frequently affected organ. The most commonly observed pattern in Kidney biopsy was membranoproliferative glomerulonephritis with endocapillary proliferation sometimes associated with extra capillary crescents, whether or not antineutrophil cytoplasmic antibodies were evidenced. Right-sided Infective Endocarditis (especially in intravenous drug users) were overrepresented (14 of the 25 cases (56.0%)) in this review. Besides antibiotics, corticosteroids were the most frequently prescribed immunosuppressive treatment both for vasculitides or glomerulonephritis. KEY MESSAGES Vasculitides and glomerulonephritis associated with Staphylococcus aureus definite Infective Endocarditis have been reported since 1976. Except kidney, organs that were more frequently affected (by small to medium size vessel vasculitis) were skin, gastrointestinal tract and peripheral nerve. The most commonly observed pattern in Kidney biopsy was membranoproliferative glomerulonephritis with endocapillary proliferation and right-sided Infective Endocarditis (especially in intravenous drug users) were overrepresented in this review.
Published: 2020

10. Obesity and Preoperative Anaemia as Independent Risk Factors for Sternal Wound Infection After Coronary Artery Bypass Graft Surgery with Pedicled (Non-Skeletonized) Internal Mammary Arteries: The Role of Thoracic Wall Ischemia?

Author: Ailsa Robbins, Vito G. Ruggieri, Sylvain Rubin, Aurélie Brunet, Odile Bajolet, Anne Poncet, Annick Lefebvre, Yves Assad Saade, Yohan Nguyen, Pathologies Pulmonaires et Plasticité Cellulaire - UMR-S 1250 (P3CELL), Université de Reims Champagne-Ardenne (URCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], and Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: Male, obesity, Time Factors, Endocrinology, Diabetes and Metabolism, [SDV]Life Sciences [q-bio], 030204 cardiovascular system & hematology, Body Mass Index, law.invention, Coronary artery disease, Hemoglobins, 0302 clinical medicine, Risk Factors, law, Pharmacology (medical), Hospital Mortality, 030212 general & internal medicine, Coronary Artery Bypass, ComputingMilieux_MISCELLANEOUS, Original Research, Aged, 80 and over, Univariate analysis, internal mammary arteries, Anemia, Hematology, General Medicine, Middle Aged, Intensive care unit, 3. Good health, Treatment Outcome, medicine.anatomical_structure, Female, Cardiology and Cardiovascular Medicine, preoperative anaemia, Thoracic wall, Artery, medicine.medical_specialty, Risk Assessment, 03 medical and health sciences, coronary artery bypass graft surgery, medicine, Humans, Surgical Wound Infection, Aged, Retrospective Studies, business.industry, Public Health, Environmental and Occupational Health, Retrospective cohort study, Perioperative, Length of Stay, medicine.disease, Sternotomy, Surgery, Vascular Health and Risk Management, Complication, business, Biomarkers
Abstract: Aurélie Brunet,1 Yohan N’Guyen,1,* Annick Lefebvre,2,* Anne Poncet,3 Ailsa Robbins,1 Odile Bajolet,2 Yves Saade,3 Vito Giovanni Ruggieri,3,* Sylvain Rubin3,* 1Internal Medicine, Infectious Diseases and Clinical Immunology, Robert Debré University Hospital, Reims, France; 2Operational Hygiene Team, Robert Debré University Hospital, Reims, France; 3Thoracic and Cardiovascular Surgery, Robert Debré University Hospital, Reims, France*These authors contributed equally to this workCorrespondence: Yohan N’GuyenInternal Medicine, Infectious Diseases and Clinical Immunology, Robert Debré University Hospital, Avenue du général Koenig, Reims 51092, FranceTel (+33) 3 26 78 94 22Fax (+33) 3 26 78 40 90Email yohan.nguyen@wanadoo.frPurpose: Obesity remains statistically associated with coronary artery disease, for which coronary artery bypass graft surgery (CABG) remains the standard of care. However, obesity is also associated with sternal wound infection (SWI) which is a severe complication of CABG despite advances in surgery and in infection prevention and control. Strategies to reduce the incidence of SWI are still being investigated, and we therefore conducted a retrospective study to revisit factors other than obesity associated with SWI after CABG.Patients and Methods: Data were extracted from the medical records of 182 patients who underwent elective on-pump CABG using one or both pedicled internal mammary artery grafts in Reims University Hospital between May 2015 and May 2016. All preoperative or perioperative variables with a p value< 0.10 in univariate analysis were entered into a stepwise logistic regression model.Results: Among the 182 patients (145 male (79.6%), median age 68.0 [45.0– 87.0] years), 138 (75.8%) underwent CABG using bilateral internal mammary artery grafts. Median BMI was 27.7 [18.7– 50.5] kg/m2, and there were 51 (28.0%) and 79 (43.4%) patients with obesity and overweight, respectively. Twenty-three out of the 182 patients (12.6%) developed SWI. In-hospital mortality was not statistically different between patients with and without SWI but the median length of stay was (6.0 [2.0– 38.0] versus 5.0[3.0– 21.0] days in the intensive care unit, p=0.03, and 26.0 [9.0– 134.0] versus 9.0 [7.0– 51.0] days in hospital, p< 0.0001). Obesity and preoperative anaemia were independently associated with SWI, as was the number of red blood cell (RBC) units transfused (OR 14.61 [2.64– 80.75], OR 4.64 [1.61– 13.34] and OR 1.27 [1.02– 1.58], respectively).Conclusion: The independent association of SWI with the number of RBC units transfused and the existence of preoperative anaemia and obesity suggests a mechanism of thoracic wall ischemia in SWI after CABG, thus leaving insufficient perfusion of the thoracic wall in patients with obesity. Medical strategies are warranted to try to prevent this costly complication.Keywords: obesity, preoperative anaemia, coronary artery bypass graft surgery, internal mammary arteries
Published: 2020

11. Pulmonary adverse events related to idelalisib therapy: A single centre experience

Author: Alain Delmer, Dominique Toubas, Yohan Nguyen, Aurélien Giltat, Caroline Migault, O. Toubas, Delphine Lebrun, François Lebargy, Gautier Julien, Firouzé Bani-Sadr, Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Matrice extracellulaire et dynamique cellulaire - UMR 7369 (MEDyC), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS), Service d'hématologie [Reims], Hôpital Robert Debré, and Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims)-Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: Male, Oncology, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Antineoplastic Agents, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Adverse effect, Lung, ComputingMilieux_MISCELLANEOUS, Aged, Quinazolinones, Pharmacology, business.industry, TOR Serine-Threonine Kinases, Pneumonia, Middle Aged, 3. Good health, Single centre, Infectious Diseases, Purines, 030220 oncology & carcinogenesis, Idelalisib, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, 030215 immunology
Abstract: Idelalisib is a potent and selective inhibitor of the PI3Kδ approved since September 2014 for the treatment of several types of B cell malignancies. Pulmonary adverse events related to idelalisib are an emerging serious adverse event. We report here a single centre cohort of 16 patients who initiated idelalisib as routine treatment. Five of them experienced severe pulmonary adverse events related to idelalisib therapy. Comparison of the 5 patients with severe pulmonary events versus the 11 patients without identified no predisposing factors. Severe pulmonary adverse events were related to infectious pneumonia and/or to a drug-induced pneumonitis. The mechanisms of idelalisib-associated pneumonitis are unknown but consistent with the drug-induced pneumonitis described with mTOR inhibitors. Indeed, by inhibiting PI3Kδ, idelalisib also inhibits the mTOR pathway. Clinicians should be aware that any idelalisib-treated patient who presents with pulmonary symptoms should be evaluated for pneumonitis. Corticosteroids should be considered in addition to anti-infective therapy in case of severe pneumonitis or persistent pulmonary symptoms despite adequate antibiotic therapy.
Published: 2018

12. Effectiveness of an education health programme about Middle East respiratory syndrome coronavirus tested during travel consultations

Author: Maxime Hentzien, Moustapha Dramé, M. Thibault, A. Brunet, A. Legall, Lukshe Kanagaratnam, Yohan Nguyen, Aurélien Giltat, Caroline Migault, Firouzé Bani-Sadr, Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), McGill University = Université McGill [Montréal, Canada], Laboratoire d'Excellence CORAIL (LabEX CORAIL), Institut de Recherche pour le Développement (IRD)-Université des Antilles et de la Guyane (UAG)-École des hautes études en sciences sociales (EHESS)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut Français de Recherche pour l'Exploitation de la Mer (IFREMER)-Université de La Réunion (UR)-Université de la Polynésie Française (UPF)-Université de la Nouvelle-Calédonie (UNC)-Institut d'écologie et environnement-Université des Antilles (UA), Université de Reims Champagne-Ardenne (URCA)-Université de Reims Champagne-Ardenne (URCA), Institut de Recherche pour le Développement (IRD)-Université des Antilles et de la Guyane (UAG)-École des hautes études en sciences sociales (EHESS)-École Pratique des Hautes Études (EPHE), Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Vieillissement, Fragilité (VIEFRA - EA 3797), and Université de Reims Champagne-Ardenne (URCA)
Subjects: Adult, Male, Health Knowledge, Attitudes, Practice, medicine.medical_specialty, Adolescent, Education health programme, Pilgrim, Middle East respiratory syndrome coronavirus, Health Promotion, medicine.disease_cause, Article, MERS-CoV, 03 medical and health sciences, 0302 clinical medicine, Pilgrims, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Surveys and Questionnaires, medicine, Humans, Travel medicine, 030212 general & internal medicine, Health Education, Referral and Consultation, Respiratory Tract Infections, ComputingMilieux_MISCELLANEOUS, Travel, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, business.industry, Transmission (medicine), 030503 health policy & services, Knowledge level, Public health, Vaccination, Public Health, Environmental and Occupational Health, General Medicine, 3. Good health, Cross-Sectional Studies, Family medicine, Middle East Respiratory Syndrome Coronavirus, Female, Hajj, France, Coronavirus Infections, 0305 other medical science, business, International travel, Program Evaluation
Abstract: Objective We aimed to evaluate the level of knowledge of Middle East respiratory syndrome coronavirus (MERS-CoV) among Hajj pilgrims before and after an education health programme during international vaccine consultations in France. Study design A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital between July 2014 and October 2015. Methods Consecutive adults (>18 years old) who attended for pre-Hajj meningococcal vaccination were eligible to complete an anonymous questionnaire with closed answers to evaluate their level of knowledge about MERS-CoV. To evaluate the effectiveness of the information given during the consultation, the same questionnaire was completed by the Hajj pilgrim before and after the consultation, where the information about MERS-CoV was provided. Results Among 82 Hajj pilgrim adults enrolled in the study, less than 25% were aware of the routes of transmission, symptoms and preventive behaviours to adopt abroad or in case of fever. Pilgrims had a higher rate of correct responses on each question at the time they completed the second questionnaire, as compared with the first, with 11 of 13 questions answered significantly better after delivery of educational information about MERS-CoV. However, although the rate of correct answers to the questions about routes of transmission, symptoms, preventive behaviours to adopt in case of fever and time delay between return and potential MERS-CoV occurrence increased significantly after receiving the information, the rates remained below 50%. Conclusion Information given during travel consultations significantly increases the general level of knowledge, but not enough to achieve epidemic control., Highlights • Information targeting the public is the preferred means to implement infection control. • The level of knowledge about MERS-CoV among Hajj pilgrims significantly increases before and after an educational health program. • However, knowledge about certain preventive behaviours remained insufficient and was not enough to achieve epidemic.
Published: 2019

13. Enterovirus persistence in cardiac cells of patients suffering from idiopathic dilated cardiomyopathy is linked to 5’ terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities

Author: Paul Fornes, Steven Tracy, Yohan Nguyen, Michel Wehbe, Nora M. Chapman, Alexis Bouin, Bert L. Semler, Nicolas Lévêque, Laurent Andreoletti, Patrick Bruneval, Michelle N. Vu, Fanny Renois, Paul-Antoine Gretteau, Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims), Université de Reims Champagne-Ardenne (URCA), Hôpital Robert Debré, Hôpital Européen Georges Pompidou [APHP] (HEGP), and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)
Subjects: viruses, [SDV]Life Sciences [q-bio], Cardiorespiratory Medicine and Haematology, 030204 cardiovascular system & hematology, Virus Replication, medicine.disease_cause, 0302 clinical medicine, Cytopathogenic Effect, Viral, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Complementary, Dilated, Medicine, viral 2Apro, Myocytes, Cardiac, Viral, viral 2A pro, Cells, Cultured, Sequence Deletion, Enterovirus, 0303 health sciences, Cultured, biology, enterovirus, High-Throughput Nucleotide Sequencing, Transfection, Genomics, Viral plaque, Enterovirus B, Human, Virus Latency, 3. Good health, Myocarditis, Cysteine Endopeptidases, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, Public Health and Health Services, RNA, Viral, Cardiology and Cardiovascular Medicine, Cardiac, 5' terminal genomic deletion, Human, Cardiomyopathy, Dilated, DNA, Complementary, Cardiomyopathy, Cells, Clinical Sciences, genomic RNA deletion, In situ hybridization, Coxsackievirus, Article, Viral Proteins, 03 medical and health sciences, 5’ terminal genomic deletion, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Physiology (medical), Complementary DNA, Idiopathic dilated cardiomyopathy, Enterovirus Infections, genomics, Humans, 030304 developmental biology, Myocytes, persistent infection, business.industry, RNA, viral 2A protease, DNA, biology.organism_classification, Virology, infection, dilated cardiomyopathy, Cardiovascular System & Hematology, Enterovirus B, 5' Untranslated Regions, business, Cytopathogenic Effect, Peptide Hydrolases
Abstract: Background: Group B enteroviruses are common causes of acute myocarditis, which can be a precursor of chronic myocarditis and dilated cardiomyopathy, leading causes of heart transplantation. To date, the specific viral functions involved in the development of dilated cardiomyopathy remain unclear. Methods: Total RNA from cardiac tissue of patients with dilated cardiomyopathy was extracted, and sequences corresponding to the 5’ termini of enterovirus RNAs were identified. After next-generation RNA sequencing, viral cDNA clones mimicking the enterovirus RNA sequences found in patient tissues were generated in vitro, and their replication and impact on host cell functions were assessed on primary human cardiac cells in culture. Results: Major enterovirus B populations characterized by 5’ terminal genomic RNA deletions ranging from 17 to 50 nucleotides were identified either alone or associated with low proportions of intact 5’ genomic termini. In situ hybridization and immunohistological assays detected these persistent genomes in clusters of cardiomyocytes. Transfection of viral RNA into primary human cardiomyocytes demonstrated that deleted forms of genomic RNAs displayed early replication activities in the absence of detectable viral plaque formation, whereas mixed deleted and complete forms generated particles capable of inducing cytopathic effects at levels distinct from those observed with full-length forms alone. Moreover, deleted or full-length and mixed forms of viral RNA were capable of directing translation and production of proteolytically active viral proteinase 2A in human cardiomyocytes. Conclusions: We demonstrate that persistent viral forms are composed of B-type enteroviruses harboring a 5’ terminal deletion in their genomic RNAs and that these viruses alone or associated with full-length populations of helper RNAs could impair cardiomyocyte functions by the proteolytic activity of viral proteinase 2A in cases of unexplained dilated cardiomyopathy. These results provide a better understanding of the molecular mechanisms that underlie the persistence of EV forms in human cardiac tissues and should stimulate the development of new therapeutic strategies based on specific inhibitors of the coxsackievirus B proteinase 2A activity for acute and chronic cardiac infections.
Published: 2019

14. Impact of Enterovirus molecular assay turnaround time on hospitalization length during an Echovirus 30 Meningitis Outbreak, France, Fall 2014

Author: Yohan Nguyen, Paul A. Gretteau, Pauline Orquevaux, Nathalie Bednarek, Laurent Andreoletti, Philippine Simphal, Christine Pietrement, Anne L. Lebreil, Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), and Hôpital universitaire Robert Debré [Reims]
Subjects: 0301 basic medicine, medicine.medical_specialty, Echovirus, medicine.disease_cause, Turnaround time, Real-time polymerase chain reaction, 03 medical and health sciences, 0302 clinical medicine, Aseptic meningitis, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Epidemiology, Medicine, 030212 general & internal medicine, ComputingMilieux_MISCELLANEOUS, Enterovirus, business.industry, Hospitalization length, Outbreak, medicine.disease, Virology, 3. Good health, 030104 developmental biology, Cerebrospinal fluid, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Hospital stay, Meningitis
Abstract: Background: The impact of Enterovirus Real Time-Polymerase Chain Reaction assay (EV RT-PCR) on hospitalization lengths of patients with aseptic meningitis has been investigated but the impact of early EV RT-PCR results released on time before patient discharge remains unclear during Echovirus meningitis outbreaks. Objective: To assess a potential correlation between EV RT-PCR turn-around time and hospitalization lengths during an Echovirus meningitis outbreak. Method: Eighteen patients demonstrating a positive EV RT-PCR assay performed on Cerebrospinal Fluid (CSF) samples collected between October 1st 2014 and December 31st 2014 were retrospectively included. Viral protein 1 (VP1) gene region was amplified and sequenced using a classical Sanger sequencing reaction. Clinical data were retrospectively collected from patient’s records. Quantitative variables expressed as median values and ranges were compared using Mann Whitney U test. Correlations were performed using simple regression analysis. Results: Phylogenetic VP1 sequence analyses identified that the outbreak was related to an Echovirus 30 strain in 7 out of the 10 cases with available sequencing data. The three remaining sequences analyses evidenced Echovirus 14, 9 and 7 strains. Hospitalization length was statistically shorter in children without comorbidity (n=5) than in adult patients (n=10) or neonates and children with comorbidity (n=3) (p=0.003 and 0.01 respectively), whereas EV RT-PCR turnaround time was not statistically different between these groups. Correlation between hospitalization length and EV RT-PCR turnaround time was poor (R2=0.06), especially in adults (R2=0.01) Conclusion: Our data indicated that EV RT-PCR turnaround time was not correlated to hospitalization length during a short Echovirus meningitis outbreak.
Published: 2019

15. Enterovirus but not Parvovirus B19 is associated with idiopathic dilated cardiomyopathy and endomyocardial CD3, CD68, or HLA-DR expression

Author: Paul Fornes, Yves Saade, Yohan Nguyen, François Lesaffre, Sophie Tassan, Fanny Renois, Camille Boulagnon, Damien Metz, and Laurent Andreoletti
Subjects: 0301 basic medicine, medicine.medical_specialty, 030204 cardiovascular system & hematology, medicine.disease_cause, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Virology, Internal medicine, Idiopathic dilated cardiomyopathy, HLA-DR, medicine, Prospective cohort study, Endocardium, biology, business.industry, Parvovirus, Dilated cardiomyopathy, biology.organism_classification, medicine.disease, 3. Good health, 030104 developmental biology, Infectious Diseases, Enterovirus, business, Viral load
Abstract: We assessed Enterovirus (EV) &Parvovirus B19 (PVB19) genomes and CD3, CD68&HLA-DR detection in dilated cardiomyopathies (DCM). EV&PVB19 genomes and CD3, CD68&HLA-DR were detected by PCR and immunohistochemistry assays in 115 endomyocardial biopsies obtained in 13 idiopathic DCM (iDCM) and 10 explained DCM (eDCM) patients. Results were compared with those of 47 atrial surgical samples (47 surgery controls) and 22 autoptic cardiac samples (11 healthy heart controls) (2008-2014, Reims, France). EV was detected in 23.1% of iDCM patients but not in eDCM and controls (P = 0.003) (viral load 803 copies/μg). PVB19 was detected in 76.9%, 80.0%, 63.6% and 78.2% of iDCM, eDCM, healthy heart and surgery controls (P = 0.99) with a mean viral load of 413, 346, 1,428, and 71 copies/μg. CD3, CD68 or HLA-DR were detected in 100 and 50% of EV and PVB19 "mono-infected" iDCM patients. EV was exclusively detected in iDCM cases in association with CD3, CD68, or HLA-DR indicating that EV could be an etiological cause in a subset of iDCM cases. By contrast the equal frequent detection of PVB19 in iDCM cases and controls without association with CD3, CD68, or HLA-DR suggested that PVB19 could be a bystander in many DCM cases. J. Med. Virol. 89:55-63, 2017. © 2016 Wiley Periodicals, Inc.
Published: 2016

16. Amoxicillin-tolerant Pasteurella multocida strain isolated from chronic dermohypodermitis after suboptimal exposure to amoxicillin is not associated with reduced growth rate

Author: Hervé Jacquier, C. Beaupuis, Firouzé Bani-Sadr, C. De Champs, Thomas Guillard, Yohan Nguyen, D. Giusti, Anne Limelette, D. Anuset, Entérobactéries Résistance Acquise - EA 4687 (ERA), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Centre Hospitalier Universitaire de Reims (CHU Reims), and Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims]
Subjects: MALDI-TOF, Maximum Growth Rate, 0301 basic medicine, Microbiology (medical), MBC, Pasteurella multocida, tid, medicine.drug_class, [SDV]Life Sciences [q-bio], 030106 microbiology, Antibiotics, Microbiology, 03 medical and health sciences, growth rate. Abbreviations: DHR 123, Minimal Inhibitory Concentration, otorhinolaryngologic diseases, medicine, Matrix Assisted Laser Desorption Ionisation time-of-flight, human, MIC, Cat scratch, ComputingMilieux_MISCELLANEOUS, amoxicillin, biology, Strain (chemistry), medicine.diagnostic_test, Human immunodeficiency virus, business.industry, HCG, ter in die (three times a day), Human chorionic gonadotropin, HIV, General Medicine, MGR, Amoxicillin, biology.organism_classification, DiHydroRhodamine 123, tolerant, 3. Good health, Minimal Bactericidal Concentration, Chronic infection, Skin biopsy, business, medicine.drug
Abstract: International audience; Pasteurella multocida is rarely observed in human chronic infections. A Pasteurella multocida strain was isolated from a skin biopsy of chronic dermohypodermitis in a 21-year-old woman without an immunocompromised state. As this strain was viable one month after a cat scratch despite treatment by amoxicillin-clavulanic acid, we compared this strain's growth rate, amoxicillin Minimal Inhibitory and Bactericidal Concentrations (MIC and MBC), resistance to serum and ability to activate neutrophil granulocytes with those of control strains isolated during acute infections in humans without previous antibiotics exposure. This particular strain was not more resistant to serum and did not induce a lower phagocytic activity than control strains. It did not grow more slowly than control strains even after suboptimal exposure to amoxicillin. This particular strain was tolerant to amoxicillin but tolerance did not appear sufficient alone for the induction of a chronic infection in a host without an immunocompromised state.
Published: 2018

17. Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report

Author: Aurélie Brunet, Firouzé Bani-Sadr, Thierry Floch, Gautier Julien, Juliette Romaru, Joël Cousson, Dominique Toubas, Delphine Lebrun, Yohan Nguyen, Aurélien Giltat, Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), Sanofi-Aventis R&D, SANOFI Recherche, Service de médecine interne [CHU Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Matrice extracellulaire et dynamique cellulaire - UMR 7369 (MEDyC), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), and Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre National de la Recherche Scientifique (CNRS)
Subjects: Adult, Male, Hemolytic anemia, Anemia, Hemolytic, medicine.medical_specialty, Combination therapy, Anemia, [SDV]Life Sciences [q-bio], 030231 tropical medicine, Artesunate, Parasitemia, Hemolysis, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Immune system, Adrenal Cortex Hormones, Internal medicine, medicine, Humans, 030212 general & internal medicine, Malaria, Falciparum, ComputingMilieux_MISCELLANEOUS, Travel, business.industry, Delayed onset, General Medicine, medicine.disease, Haemolysis, Artemisinins, 3. Good health, Coombs Test, Corticosteroid therapy, chemistry, Administration, Intravenous, business
Abstract: Delayed onset haemolysis occurring post-artesunate and post-artemisinin combination therapy is secondary to delayed clearance of infected erythrocytes spared by pitting during treatment. We report a case of severe post-treatment delayed haemolytic anaemia with a positive direct antiglobulin test and a positive response to corticosteroid therapy, suggesting an associated immune mechanism.
Published: 2017

18. Factors Associated with Geophagy and Knowledge About Its Harmful Effects Among Native Sub-Saharan African, Caribbean and French Guiana HIV Patients Living in Northern France

Author: Moustapha Dramé, Dorothée Lambert, Maxime Hentzien, Yohan Nguyen, Ailsa Robbins, Christine Rouger, Delphine Lebrun, Isabelle Kmiec, Firouzé Bani-Sadr, Jean Luc Berger, Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), and Université Pierre et Marie Curie - Paris 6 (UPMC)
Subjects: Adult, Male, Health Knowledge, Attitudes, Practice, medicine.medical_specialty, Pediatrics, Sub saharan, Social Psychology, AFRICAN CARIBBEAN, Anemia, 030231 tropical medicine, Human immunodeficiency virus (HIV), HIV Infections, medicine.disease_cause, Feeding and Eating Disorders, Soil, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Environmental health, Ethnicity, Prevalence, medicine, Humans, 030212 general & internal medicine, Pica (disorder), Africa South of the Sahara, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Anemia, Iron-Deficiency, business.industry, Public health, Public Health, Environmental and Occupational Health, medicine.disease, French Guiana, 3. Good health, Infectious Diseases, Caribbean Region, Pica, Hiv patients, Female, France, medicine.symptom, business
Abstract: Geophagy, or the ingestion of earth or clay, is widespread among women of Sub-Saharan African, Caribbean or French Guiana origin. Little is known about this practice among HIV patients native of these countries and who are followed-up in France. The aims of this study were to determine (i) the prevalence and factors associated with geophagy among HIV patients native of these countries, (ii) patients' knowledge about the harmful effects of geophagy, and (iii) the association of geophagy with iron deficiency, or a history of anemia or constipation. Among the 119 included patients, current geophagy and previous geophagy were present in 11/119 (9%) and 47/119 (40%) patients, respectively. Female gender was the only factor associated with consumption (OR 5.37; 95% CI 2.07-15.92 p = 0.001). Awareness about the risk of iron-deficient anemia was low (24%). Preventive education should be integrated into the care of HIV adults from countries in which geophagy is a culture and widely accepted practice.
Published: 2017

19. Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration

Author: Alain Delmer, Yohan Nguyen, Véronique Vernet-Garnier, Christophe Strady, Christophe de Champs, Maxime Hentzien, Amélie Servettaz, Firouzé Bani-Sadr, Centre Hospitalier Universitaire de Reims (CHU Reims), Polyclinique Saint André, Service d'hématologie [Reims], Hôpital Robert Debré, and Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims)-Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: 0301 basic medicine, Microbiology (medical), Adult, Coagulase, Male, medicine.medical_specialty, Staphylococcus, [SDV]Life Sciences [q-bio], 030106 microbiology, Bacteremia, Microbial Sensitivity Tests, medicine.disease_cause, Hospitals, University, 03 medical and health sciences, Minimum inhibitory concentration, 0302 clinical medicine, Vancomycin, Internal medicine, Medicine, Humans, 030212 general & internal medicine, Hospital Mortality, ComputingMilieux_MISCELLANEOUS, Aged, Retrospective Studies, General Immunology and Microbiology, In hospital mortality, business.industry, Proportional hazards model, cons, General Medicine, Middle Aged, Staphylococcal Infections, University hospital, Prognosis, 3. Good health, Surgery, Anti-Bacterial Agents, Infectious Diseases, Treatment Outcome, Female, business, medicine.drug
Abstract: The impact of a minimum inhibitory concentration (MIC) of vancomycin ≥2 mg/L on mortality and the potential benefit of new antistaphylococcal treatments in coagulase-negative Staphylococcus (CoNS) bacteraemia remain unknown. We assessed the impact of vancomycin MIC on 30-day in-hospital mortality and identified factors independently associated with 30-day in-hospital mortality.All patients presenting significant CoNS bacteraemia in the university hospital of Reims, between 01 January 2008 and 31 December 2012, were included. Data were retrospectively extracted from the patient records. Vancomycin MIC was assessed using the E-test method, and antimicrobial susceptibility testing was performed in accordance with the recommendations of the Antibiogram Committee of the French Microbiology Society. Cox's Proportional Hazards model was used for multivariate analysis.Two hundred and sixty-nine patients (mean age 61.2 ± 15.7 years) were included. Foreign material was present in 92% of patients and 78.4% of isolated methicillin-resistant strains had vancomycin MIC ≥2 mg/l. Thirty-day in-hospital mortality was 16%. There was no association between vancomycin MIC ≥2 mg/l and 30-day in-hospital mortality (adjusted Hazard Ratio (aHR) = .80, 95% confidence interval (95%CI) [.30-2.19], p = .67). Factors independently associated with 30-day in-hospital mortality were age ≥75 vs. ≤60 years (aHR =3.72, 95%CI [1.39-9.97], p = .009), absence of active antibiotic treatment (aHR =5.52, 95%CI [1.13-26.87], p = .03) and acute renal failure (aHR =4.45, 95%CI [2.08-9.56], p .0001). Removal of an infected device had a protective effect against 30-day in-hospital mortality (aHR = .23, 95%CI [.11-.48], p .0001).These results suggest that CoNS bacteraemia should be managed by removal of the infected device and antibiotic treatment such as vancomycin.
Published: 2017

20. Knowledge of antibiotics and antibiotic resistance in patients followed by family physicians

Author: Moustapha Dramé, Brigitte Vuillemin, Véronique Vernet-Garnier, Odile Bajolet, Bernard Defoin, Firouzé Bani-Sadr, Yohan Nguyen, Aurélien Robert, Centre d'Ecologie et des Sciences de la COnservation (CESCO), Muséum national d'Histoire naturelle (MNHN)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Unité d’Otologie, implants auditifs et chirurgie de la base du crâne [CHU Pitié-Salpêtrière], Service d'Oto-Rhino-Laryngologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Reims Champagne-Ardenne (URCA), Laboratoire Interdisciplinaire Carnot de Bourgogne (LICB), Université de Bourgogne (UB)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire Interdisciplinaire Carnot de Bourgogne (ICB), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Subjects: Adult, Male, 0301 basic medicine, Health Knowledge, Attitudes, Practice, Pediatrics, medicine.medical_specialty, medicine.drug_class, 030106 microbiology, Antibiotics, Target groups, Drug resistance, Logistic regression, Cultural background, 03 medical and health sciences, 0302 clinical medicine, Antibiotic resistance, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Resistance, Bacterial, medicine, Humans, In patient, 030212 general & internal medicine, Antibiotic use, Intensive care medicine, ComputingMilieux_MISCELLANEOUS, business.industry, Middle Aged, Anti-Bacterial Agents, 3. Good health, Cross-Sectional Studies, Infectious Diseases, Female, Self Report, Family Practice, business
Abstract: Objective We aimed to evaluate factors associated with knowledge of antibiotics and drug resistance. Methods A questionnaire was handed out by 14 family physicians to their patients between December 20, 2014 and April 20, 2015 in Rethel (North-East of France). We conducted a cross-sectional study using a logistical regression model to assess factors associated with antibiotic knowledge. Three criteria were used to assess that knowledge. Results Overall, 293 questionnaires were analysed; 48% of patients had received antibiotics in the previous 12 months. Only 44% and 26% gave a correct answer for the statements “Antibiotics are effective against bacteria and ineffective against viruses” and “Antibiotic resistance decreases if the antibiotic use decreases”, respectively. Characteristics such as female sex, age > 30 years, high level of education, high professional categories, and having received antibiotic information by the media were associated with high level of knowledge about antibiotics and/or antibiotic resistance. In contrast, having received antibiotic information from family physicians was not associated with good knowledge. Conclusion Although media awareness campaigns had an independent impact on a higher public knowledge of antibiotics, the overall public knowledge remains low. It would be necessary to strengthen antibiotic campaigns with clearer information on the relation between the excessive use of antibiotics and the increased risk of antibiotic resistance. Family physicians should be more involved to improve antibiotic knowledge among target groups such as men, young patients, and people from a poor social and cultural background.
Published: 2017

21. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae

Author: Jean-Ralph Zahar, Philippe Lesprit, Stephane Ruckly, Aurelia Eden, Hitoto Hikombo, Louis Bernard, Stephan Harbarth, Jean-François Timsit, Christian Brun-Buisson, Nejla Aissa, Alain Losniewski, Sandrine Henard, Christian Rabaud, Cécile Janssen, Léonardo Pagani, Stéphane Bland, Jacques Gaillat, Jean Pierre Bru, Pierre Bonnin, Gaelle Clavère, Virginie Vitrat, Laurence Maulin, Luc Quarsaet, Helene Roger, Jean-Baptiste Euzen, Eric Denes, Elodie Couve-Daecon, Catherine Lechiche, Jean-Philippe Lavigne, Véronique Mondain, Celine Pulcini, Veronique Garnier, Dorothée Lambert, Maxime Hentzien, Yohan Nguyen, Jean Paul Talarmin, Pascaline Rameau, Françoise Geffroy, Arnaud Salmon-Rousseau, Vincent Cattoir, Antoine Froissart, Said Aberrane, Laurence Legout, France Roblot, Guillaume Beraud, Patricia Pavese, Olivier Belmonte, Nicolas Traversier, Laurent Bellec, Marie Lagrange-Xelot, Marie-Pierre Moiton, Barbara Kuli, Pascal Longuet, Agnes Scanvic, Lea Colombain, Milagros Ferreyra, Maxime Jean, Etienne Laurens, Matthieu Saada, Hugues Aumaitre, Martine Malet, Frederique Roustant, Vincent LeMoing, Jean-Pierre Helene, Jonathan Theodore, Caroline Garandeau, Jocelyne Caillon, Benjamin Olivero, David Boutoille, Didier Lepelletier, Lucia Grandière-Perez, Aurélie Beaudron, Céline Ramanantsoa, Catherine Varache, Nicolas Varache, Nicolas Crochette, Hikombo Hitoto, Sophie Blanchi, Pascale Penn, Bernard Louis, Dominique Vanjak, Marie-Christine Escande, René-Gilles Patrigeon, Stéphanie Honoré, Audrey Barrelet, Marlène Amara, Jean-Marc Galempoix, Jean-Claude Réveil, Patricia Bucchiotty, Carine Couzigou, Alban LeMonnier, Emilie Boidin, Stephane Sire, Nelly Luizy, Caroline Bronstain, Carolina Fankhauser, Caroline Brossier, Elodie von Dach, Colette Sauve, Marie-Noelle Adam, Laurent Hocqueloux, Laurent Bret, Marie-Hélène André, Régine Barruet, Marion Challier, Andre Cabié, Benoit Roze, Patrick Plesiat, Katy Jeanot, Isabelle Patry, Joséphine Moreau, Catherine Chirouze, Aaron Laurent, Marie-Nadège Bachelier, Guillaume Kac, Nicolas Farthouat, Nicolas Feuillebois, Thomas Guimard, Sandra Bourdon, Sophie Nguyen, Serge Alfandari, Houcine Bentayeb, Mari-Thérèse Albertini, Bruno Marchou, Noémie Gaudré, Damien Dubois, Christelle Guillet-Caruba, Florence Doucet Populaire, Nicolas Fortineau, Leila Escaut, Vincent Fihman, Rémy Gauzit, Josette Raymond, Solene Kerneis, Veronique Leflon-Guibout, Agnes Lefort, Aurelien Dinh, Anne-Laure Roux, Sophie Abgrall, Françoise Jauréguy, Jean-Christophe Lucet, Nathalie Soismier, Amanda Lopes, Emmanuelle Cambau, Veronique Manceron, Guilène Barnaud, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Hôpital Foch [Suresnes], Outcomerea, Centre Hospitalier Saint Jean de Perpignan, Centre Hospitalier Le Mans (CH Le Mans), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Faculté de médecine [Genève], Prévention et contrôle des infections (PCI ), Hôpitaux Universitaires de Genève (HUG), Services de Maladies Infectieuses et Tropicales [CHU Bichat], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de réanimation médicale, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)
Subjects: Male, 0301 basic medicine, Pediatrics, Bacteremia, Community-Acquired Infections/epidemiology/microbiology, Antibiotic appropriateness, Klebsiella spp, 0302 clinical medicine, Healthcare associated, Risk Factors, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Prevalence, Risk of mortality, Medicine, Pharmacology (medical), Prospective Studies, 030212 general & internal medicine, beta-Lactamases/secretion, Community onset, ddc:616, Aged, 80 and over, Cross Infection, education.field_of_study, biology, Enterobacteriaceae Infections, General Medicine, Middle Aged, Enterobacteriaceae, 3. Good health, Community-Acquired Infections, Treatment Outcome, Infectious Diseases, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Cross Infection/microbiology, Female, Bacteremia/epidemiology/microbiology, Microbiology (medical), medicine.medical_specialty, 030106 microbiology, Population, beta-Lactamases, 03 medical and health sciences, Extended-spectrum β-lactamase, Antibiotic therapy, Enterobacteriaceae/classification/enzymology/isolation & purification, Humans, Risk factor, education, Aged, Enterobacteriaceae Infections/epidemiology/microbiology, business.industry, biochemical phenomena, metabolism, and nutrition, biology.organism_classification, bacterial infections and mycoses, Survival Analysis, Risk factors, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Bacteraemia, business
Abstract: International audience; Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) are endemic pathogens worldwide. Infection with ESBL-PE may be associated with inadequate antibiotic therapy and a poor outcome. However, risk factors for ESBL-PE community-acquired infections are ill-defined. An observational multicentre study was performed in 50 hospitals to identify the prevalence of and risk factors for community-acquired ESBL-PE bacteraemia. All patients presenting with community-onset Enterobacteriaceae bacteraemia were recorded over a 2-month period (between June and November 2013). Risk factors and 14-day outcomes of patients were investigated. Among 682 Enterobacteriaceae bacteraemia episodes recorded, 58 (8.5%) were caused by ESBL-PE. The most frequent species isolated were Escherichia coli (537; 76.7%) and Klebsiella spp. (68; 9.7%), of which 49 (9.1%) and 8 (11.8%), respectively, were ESBL-producers. Most ESBL-PE episodes were healthcare-associated, and only 22 (38%) were apparently community-acquired. The main risk factor for community-acquired ESBL-PE bacteraemia was a prior hospital stay of ≥5 days within the past year. The overall 14-day survival was 90%; only 4 (6.9%) of 58 patients with ESBL-PE bacteraemia died. Inadequate initial antibiotic therapy was administered to 55% of patients with ESBL-PE bacteraemia but was not associated with increased 14-day mortality. Although many patients had community-onset ESBL-PE bacteraemia, almost two-thirds of the episodes were actually healthcare-associated, and true community-acquired ESBL-PE bacteraemia remains rare. In our essentially non-severely ill population, inappropriate initial therapy was not associated with a higher risk of mortality.
Published: 2017

22. Erratum to 'Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae' [International Journal of Antimicrobial Agents 49/1 67-73]

Author: Jean-Ralph Zahar, Philippe Lesprit, Stephane Ruckly, Aurelia Eden, Hitoto Hikombo, Louis Bernard, Stephan Harbarth, Jean-Francois Timsit, Christian Brun-Buisson, Jean Carlet, Pierre Dellamonica, Remy Gauzit, Christian Rabaud, Serge Alfandari, Robert Cohen, Bruno Coignard, Celine Pulcini, Jerome Robert, Nejla Aissa, Alain Losniewski, Sandrine Henard, Cecile Janssen, Leonardo Pagani, Stephane Bland, Jacques Gaillat, Jean Pierre Bru, Pierre Bonnin, Gaelle Clavere, Virginie Vitrat, Laurence Maulin, Luc Quarsaet, Helene Roger, Jean-Baptiste Euzen, Eric Denes, Elodie Couve-Daecon, Catherine Lechiche, Jean-Philippe Lavigne, Veronique Mondain, Veronique Garnier, Dorothee Lambert, Maxime Hentzien, Yohan Nguyen, Jean Paul Talarmin, Pascaline Rameau, Francoise Geffroy, Arnaud Salmon-Rousseau, Vincent Cattoir, Antoine Froissart, Said Aberrane, Laurence Legout, France Roblot, Guillaume Beraud, Patricia Pavese, Olivier Belmonte, Nicolas Traversier, Laurent Bellec, Marie Lagrange-Xelot, Marie-Pierre Moiton, Barbara Kuli, Pascal Longuet, Agnes Scanvic, Lea Colombain, Milagros Ferreyra, Maxime Jean, Etienne Laurens, Matthieu Saada, Hugues Aumaitre, Martine Malet, Frederique Roustant, Vincent LeMoing, Jean-Pierre Helene, Jonathan Theodore, Caroline Garandeau, Jocelyne Caillon, Benjamin Olivero, David Boutoille, Didier Lepelletier, Lucia Grandiere-Perez, Aurelie Beaudron, Celine Ramanantsoa, Catherine Varache, Nicolas Varache, Nicolas Crochette, Hikombo Hitoto, Sophie Blanchi, Pascale Penn, Bernard Louis, Dominique Vanjak, Marie-Christine Escande, Rene-Gilles Patrigeon, Stephanie Honore, Audrey Barrelet, Marlene Amara, Jean-Marc Galempoix, Jean-Claude Reveil, Patricia Bucchiotty, Carine Couzigou, Alban LeMonnier, Emilie Boidin, Stephane Sire, Nelly Luizy, Caroline Bronstain, Carolina Fankhauser, Caroline Brossier, Elodie von Dach, Colette Sauve, Marie-Noelle Adam, Laurent Hocqueloux, Laurent Bret, Marie-Helene Andre, Regine Barruet, Marion Challier, Andre Cabie, Benoit Roze, Patrick Plesiat, Katy Jeanot, Isabelle Patry, Josephine Moreau, Catherine Chirouze, Aaron Laurent, Marie-Nadege Bachelier, Guillaume Kac, Nicolas Farthouat, Nicolas Feuillebois, Thomas Guimard, Sandra Bourdon, Sophie Nguyen, Houcine Bentayeb, Mari-Therese Albertini, Bruno Marchou, Noemie Gaudre, Damien Dubois, Christelle Guillet-Caruba, Florence Doucet Populaire, Nicolas Fortineau, Leila Escaut, Vincent Fihman, Josette Raymond, Solene Kerneis, Veronique Leflon-Guibout, Agnes Lefort, Aurelien Dinh, Anne-Laure Roux, Sophie Abgrall, Francoise Jaureguy, Jean-Christophe Lucet, Nathalie Soismier, Amanda Lopes, Emmanuelle Cambau, Veronique Manceron, Guilene Barnaud, Hôpital Avicenne [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Foch [Suresnes], Centre Hospitalier Saint Jean de Perpignan, Service d'Infectiologie et des maladies infectieuses et tropicales [CH Le Mans] | Infectious and tropical disease department [Le Mans hospital], Centre Hospitalier Le Mans (CH Le Mans), Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Prévention et contrôle des infections (PCI ), Hôpitaux Universitaires de Genève (HUG), Services de Maladies Infectieuses et Tropicales [CHU Bichat], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service des maladies infectieuses, Centre Hospitalier Universitaire de Nice (CHU Nice)-University Hospital, Hôpital Cochin [AP-HP], Service des Maladies Infectieuses et Tropicales [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Réseau Antibiolor, Stress, Immunité, Pathogènes (SIMPA), Université de Lorraine (UL), Centre Hospitalier Tourcoing, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA), Institut de minéralogie, de physique des matériaux et de cosmochimie (IMPMC), Muséum national d'Histoire naturelle (MNHN)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de recherche pour le développement [IRD] : UR206-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Bactériologie [CHU Nancy], Institute for Computational Modeling in Civil Engineering, Technische Universität Braunschweig = Technical University of Braunschweig [Braunschweig], Imperial College London, Service des Maladies Infectieuses, Centre Hospitalier de la Région d'Annecy (Pringy), Service des Maladies infectieuses et tropicales [CHU Limoges], CHU Limoges, Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA), Centre Hospitalier Universitaire de Reims (CHU Reims), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CH Cornouaille, Plateforme imagerie et cytométrie (PFIC), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service NEUROSPIN (NEUROSPIN), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institute of New Imaging Technologies (INIT), Universitat Jaume I, Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), Unité des maladies infectieuses, Hôpital Bichat - Claude Bernard, CHU Pontchaillou [Rennes], Laboratoire Cliniques Pathologique et Interculturelle (LCPI), Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université de Toulouse (UT), SAD Paysage (SAD Paysage), Institut National de la Recherche Agronomique (INRA)-AGROCAMPUS OUEST, Service des maladies infectieuses CHU Perpignan, Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Département de Chimie Moléculaire (DCM), Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Thérapeutiques cliniques et expérimentales des infections (EA 3826) (EA 3826), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Centre de Recherche en Ingénierie financière et finance Publique (CRIFP), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA), Service des maladies infectieuses et tropicales [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), Service de bactériologie et hygiène hospitalière [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de Recherches en Oncologie biologique et Oncopharmacologie (CRO2), Aix Marseille Université (AMU)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier de Charleville-Mezières, Université de Bordeaux (UB), Institut de Recherche Dupuy de Lôme (IRDL), École Nationale d'Ingénieurs de Brest (ENIB)-Université de Bretagne Sud (UBS)-Université de Brest (UBO)-École Nationale Supérieure de Techniques Avancées Bretagne (ENSTA Bretagne)-Centre National de la Recherche Scientifique (CNRS), Department of Cell Biology, Sciences III, Université de Genève = University of Geneva (UNIGE), Université Laval [Québec] (ULaval), Service de Maladies Infectieuses et Tropicales [Fort-de-France, Martinique], CHU de la Martinique [Fort de France]-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France]-Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], CHU Fort de France-CHU de la Martinique [Fort de France]-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France], Agents pathogènes et inflammation - UFC (EA 4266) (API), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Institut de l'élevage (IDELE), Laboratoire Chrono-environnement (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques, Laboratoire d'Informatique de l'Université du Mans (LIUM), Le Mans Université (UM), Physiopathologie de l'Endothelium, Vascular research center of Marseille (VRCM), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], Université de Sherbrooke (UdeS), Centre hospitalier universitaire de Tourcoing, Homéostasie Cellulaire et Pathologies (HCP), Université de Limoges (UNILIM)-CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Laboratoire Montpelliérain d'Économie Théorique et Appliquée (LAMETA), Université Montpellier 1 (UM1)-Université Paul-Valéry - Montpellier 3 (UPVM)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Faculty of Mathematics, Informatics, and Mechanics [Warsaw] (MIMUW), University of Warsaw (UW), Service de Microbiologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon [AP-HP], Services des maladies infectieuses, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Raymond Poincaré [AP-HP], Institut de Planétologie et d'Astrophysique de Grenoble (IPAG), Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Observatoire des Sciences de l'Univers de Grenoble (OSUG ), Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut national des sciences de l'Univers (INSU - CNRS)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Université Paris 13 (UP13)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Avicenne [AP-HP], Université Paris Diderot - Paris 7 (UPD7), Département de Médecine interne [Lariboisière], Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Emergence de la résistance bactérienne in vivo (EA3964), AP-HP Groupe Hospitalier Lariboisière, Laboratoire d'ethnologie et de sociologie comparative (LESC), Université Paris Nanterre (UPN)-Centre National de la Recherche Scientifique (CNRS), Muséum national d'Histoire naturelle (MNHN), Equipe mobile d'infectiologie, CHU Necker - Enfants Malades [AP-HP], Service Microbiologie-Hygiène Hospitalière, Institut franco-allemand de recherche de Saint-Louis, Centre Hospitalier Universitaire [Grenoble] (CHU), Unité d’Otologie, implants auditifs et chirurgie de la base du crâne [CHU Pitié-Salpêtrière], Service d'Oto-Rhino-Laryngologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), CHU Toulouse [Toulouse], Institut de recherche en astrophysique et planétologie (IRAP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut national des sciences de l'Univers (INSU - CNRS)-Observatoire Midi-Pyrénées (OMP), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Institut de Recherche pour le Développement (IRD)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Météo-France -Centre National de la Recherche Scientifique (CNRS), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Epidémiologie pronostique des cancers et affections graves, Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), Infection Control Programme and WHO Collaborating Centre on Patient Safety, CHU Cochin [AP-HP], Université Nice Sophia Antipolis (... - 2019) (UNS), Université Côte d'Azur (UCA), Institut de recherche pour le développement [IRD] : UR206-Centre National de la Recherche Scientifique (CNRS)-Muséum national d'Histoire naturelle (MNHN)-Université Pierre et Marie Curie - Paris 6 (UPMC), Technische Universität Braunschweig [Braunschweig], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Observatoire Midi-Pyrénées (OMP), Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Génie Informatique et Ingénierie de Production (LGI2P), IMT - MINES ALES (IMT - MINES ALES), Institut Mines-Télécom [Paris] (IMT)-Institut Mines-Télécom [Paris] (IMT), Service d'Otologie, Implants auditifs et Chirurgie de la base du crâne [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Santé publique : épidémiologie et qualité des soins-EA 2694 (CERIM), Recherches Translationnelles sur le VIH et les maladies infectieuses (TransVIHMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Recherche pour le Développement (IRD)-Université Montpellier 1 (UM1)-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Universtié Yaoundé 1 [Cameroun]-Université de Montpellier (UM), Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA), Université de Bretagne Sud (UBS)-Université de Brest (UBO)-École Nationale Supérieure de Techniques Avancées Bretagne (ENSTA Bretagne)-Centre National de la Recherche Scientifique (CNRS), University of Geneva [Switzerland], Université Laval, Fonctionnement et conduite des systèmes de culture tropicaux et méditerranéens (UMR SYSTEM), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Centre International de Hautes Etudes Agronomiques Méditerranéennes - Institut Agronomique Méditerranéen de Montpellier (CIHEAM-IAMM), Centre International de Hautes Études Agronomiques Méditerranéennes (CIHEAM)-Centre International de Hautes Études Agronomiques Méditerranéennes (CIHEAM)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Wageningen University and Research Centre [Wageningen] (WUR), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon), Institut de l'Elevage, Laboratoire Chrono-environnement - UFC (UMR 6249) (LCE), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon)-Hôpital Saint-Jacques, Service des maladies infectieuses et réanimation médicale, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou, Université de Sherbrooke [Sherbrooke], Hôpital Purpan [Toulouse], Université Montpellier 1 (UM1)-Université Paul-Valéry - Montpellier 3 (UM3)-Institut National de la Recherche Agronomique (INRA)-Centre international d'études supérieures en sciences agronomiques (Montpellier SupAgro)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut national d’études supérieures agronomiques de Montpellier (Montpellier SupAgro), Faculty of Mathematics, Informatics, and Mechanics [Warsaw], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP Hôpital Raymond Poincaré [Garches], Observatoire des Sciences de l'Univers de Grenoble (OSUG), Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS), Hôpital Avicenne-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris 13 (UP13), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Université Paris Diderot - Paris 7 (UPD7)-Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), COMUE Université Côte d'Azur (2015 - 2019) (COMUE UCA), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de recherche pour le développement [IRD] : UR206-Muséum national d'Histoire naturelle (MNHN)-Centre National de la Recherche Scientifique (CNRS), Institut national des sciences de l'Univers (INSU - CNRS)-Université Toulouse III - Paul Sabatier (UT3), Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université, Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), COMUE Université Côte d'Azur (2015 - 2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015 - 2019) (COMUE UCA), Institut National de la Santé et de la Recherche Médicale (INSERM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Aix Marseille Université (AMU), Centre National de la Recherche Scientifique (CNRS)-École Nationale Supérieure de Techniques Avancées Bretagne (ENSTA Bretagne)-Université de Brest (UBO)-Université de Bretagne Sud (UBS), Wageningen University and Research [Wageningen] (WUR), CHU Fort de France-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France]-CHU de la Martinique [Fort de France], Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Service des maladies infectieuses et réanimation médicale [Rennes], Hôpital Beaujon [AP-HP], Cholley, Pascal, Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Brest (UBO)-Centre National de la Recherche Scientifique (CNRS)-École Nationale Supérieure de Techniques Avancées Bretagne (ENSTA Bretagne)-Université de Bretagne Sud (UBS), Université Paris Diderot - Paris 7 (UPD7)-Hôpital Lariboisière-Fernand-Widal [APHP], Université Joseph Fourier - Grenoble 1 ( UJF ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), CHU Nice-University Hospital, Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Laboratoire de Physiologie des Invertébrés ( LPI ), Institut Français de Recherche pour l'Exploitation de la Mer ( IFREMER ), Laboratoire des Sciences de l'Environnement Marin (LEMAR) ( LEMAR ), Institut de Recherche pour le Développement ( IRD ) -Institut Français de Recherche pour l'Exploitation de la Mer ( IFREMER ) -Université de Brest ( UBO ) -Institut Universitaire Européen de la Mer ( IUEM ), Institut de Recherche pour le Développement ( IRD ) -Université de Brest ( UBO ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université de Brest ( UBO ) -Centre National de la Recherche Scientifique ( CNRS ) -Centre National de la Recherche Scientifique ( CNRS ), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale ( SESSTIM ), Institut de Recherche pour le Développement ( IRD ) -Aix Marseille Université ( AMU ) -ORS PACA-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Nice Sophia Antipolis ( UNS ), Université Côte d'Azur ( UCA ), Institut de minéralogie, de physique des matériaux et de cosmochimie ( IMPMC ), Muséum National d'Histoire Naturelle ( MNHN ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut de recherche pour le développement [IRD] : UR206-Centre National de la Recherche Scientifique ( CNRS ), Institut de recherche en astrophysique et planétologie ( IRAP ), Université Paul Sabatier - Toulouse 3 ( UPS ) -Observatoire Midi-Pyrénées ( OMP ) -Centre National de la Recherche Scientifique ( CNRS ), Equipe Poitevine de Recherche et d'Encadrement Doctoral en sciences criminelles de Poitiers ( EPRED ), Université de Poitiers, Laboratoire de Génie Informatique et Ingénierie de Production ( LGI2P ), IMT - Mines Alès Ecole Mines - Télécom ( IMT - MINES ALES ), Institut National des Sciences Appliquées de Lyon ( INSA Lyon ), Université de Lyon-Institut National des Sciences Appliquées ( INSA ), Laboratoire de Physique Corpusculaire - Clermont-Ferrand ( LPC ), Université Blaise Pascal - Clermont-Ferrand 2 ( UBP ) -Institut National de Physique Nucléaire et de Physique des Particules du CNRS ( IN2P3 ) -Centre National de la Recherche Scientifique ( CNRS ), Centre Hospitalier Universitaire de Reims ( CHU de Reims ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Pitié-Salpêtrière [APHP], Plateforme imagerie et cytométrie ( PFIC ), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse ( AMMICa ), Université Paris-Sud - Paris 11 ( UP11 ) -Institut Gustave Roussy ( IGR ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Paris-Sud - Paris 11 ( UP11 ) -Institut Gustave Roussy ( IGR ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Service NEUROSPIN ( NEUROSPIN ), Direction de Recherche Fondamentale (CEA) ( DRF (CEA) ), Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Université Paris-Saclay-Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Université Paris-Saclay, CHU de Poitiers, Santé publique : épidémiologie et qualité des soins-EA 2694 ( CERIM ), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Institute of New Imaging Technologies ( INIT ), Centre Hospitalier Universitaire de La Réunion ( CHU La Réunion ), Laboratoire Cliniques Pathologique et Interculturelle ( LCPI ), Université Toulouse - Jean Jaurès ( UT2J ), SAD Paysage ( SAD Paysage ), Institut National de la Recherche Agronomique ( INRA ) -AGROCAMPUS OUEST, VIH/SIDA et maladies associées, Université Montpellier 1 ( UM1 ), Département de Chimie Moléculaire ( DCM ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Grenoble Alpes ( UGA ), Thérapeutiques Cliniques et Expérimentales des Infections, Université de Nantes ( UN ), Centre de Recherche en Ingénierie financière et finance Publique ( CRIFP ), Université Côte d'Azur ( UCA ) -Université Côte d'Azur ( UCA ), Centre hospitalier universitaire de Nantes ( CHU Nantes ), Université de Nantes ( UN ) -Centre hospitalier universitaire de Nantes ( CHU Nantes ), Hôpital de la Timone [CHU - APHM] ( TIMONE ), Centre de Recherches en Oncologie biologique et Oncopharmacologie ( CRO2 ), Aix Marseille Université ( AMU ) - Hôpital de la Timone [CHU - APHM] ( TIMONE ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université de Bordeaux ( UB ), Laboratoire Environnement Géomécanique et Ouvrages ( LAEGO ), Institut National Polytechnique de Lorraine ( INPL ), Institut de Recherche Dupuy de Lôme ( IRDL ), Centre National de la Recherche Scientifique ( CNRS ) -ENSTA Bretagne-Université de Brest ( UBO ) -Université de Bretagne Sud ( UBS ), Fonctionnement et conduite des systèmes de culture tropicaux et méditerranéens ( SYSTEM ), Centre de Coopération Internationale en Recherche Agronomique pour le Développement ( CIRAD ) -Institut National de la Recherche Agronomique ( INRA ) -Centre international d'études supérieures en sciences agronomiques ( Montpellier SupAgro ) -Institut national d’études supérieures agronomiques de Montpellier ( Montpellier SupAgro ), Wageningen University and Research Centre [Wageningen] ( WUR ), CHU de la Martinique-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique-Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], CHU Fort de France-CHU de la Martinique-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique, Agents pathogènes et inflammation - UFC (EA 4266) ( API ), Université de Franche-Comté ( UFC ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ), Laboratoire Chrono-environnement ( LCE ), Université Bourgogne Franche-Comté ( UBFC ) -Centre National de la Recherche Scientifique ( CNRS ) -Université de Franche-Comté ( UFC ), Centre Hospitalier Régional Universitaire [Besançon] ( CHRU Besançon ) -Hôpital Saint-Jacques, Laboratoire d'Informatique de l'Université du Mans ( LIUM ), Le Mans Université ( UM ), Vascular research center of Marseille ( VRCM ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Aix Marseille Université ( AMU ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Aix Marseille Université ( AMU ), Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Hôpital Pontchaillou, Homéostasie Cellulaire et Pathologies ( HCP ), Université de Limoges ( UNILIM ) -CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique ( GEIST FR CNRS 3503 ), Hôpital Purpan - Centre Hospitalier Universitaire (CHU) de Toulouse, Laboratoire Montpelliérain d'Économie Théorique et Appliquée ( LAMETA ), Université Montpellier 1 ( UM1 ) -Université Paul-Valéry - Montpellier 3 ( UM3 ) -Centre international d'études supérieures en sciences agronomiques ( Montpellier SupAgro ) -Institut national de la recherche agronomique [Montpellier] ( INRA Montpellier ) -Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut national d’études supérieures agronomiques de Montpellier ( Montpellier SupAgro ), University of Warsaw ( UW ), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Diderot - Paris 7 ( UPD7 ) -Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP Hôpital Raymond Poincaré [Garches], Institut de Planétologie et d'Astrophysique de Grenoble ( IPAG ), Observatoire des Sciences de l'Univers de Grenoble ( OSUG ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Institut national des sciences de l'Univers ( INSU - CNRS ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Grenoble Alpes ( UGA ) -Université Joseph Fourier - Grenoble 1 ( UJF ) -Institut national des sciences de l'Univers ( INSU - CNRS ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Grenoble Alpes ( UGA ) -Centre National de la Recherche Scientifique ( CNRS ), Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Avicenne-Université Paris 13 ( UP13 ), Infection, Antimicrobiens, Modélisation, Evolution ( IAME ), Université Paris 13 ( UP13 ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Paris Diderot - Paris 7 ( UPD7 ), Université Paris Diderot - Paris 7 ( UPD7 ) -Hôpital Lariboisière, Emergence de la résistance bactérienne in vivo ( EA3964 ), Laboratoire d'ethnologie et de sociologie comparative ( LESC ), Université Paris Nanterre ( UPN ) -Centre National de la Recherche Scientifique ( CNRS ), Muséum National d'Histoire Naturelle ( MNHN ), Hopital Necker-Enfants Malades, Centre Hospitalier Universitaire [Grenoble] ( CHU ), Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 ( UPEC UP12 ), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-CHU Limoges, and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris 13 (UP13)
Subjects: Microbiology (medical), 0303 health sciences, medicine.medical_specialty, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, biology, 030306 microbiology, business.industry, General Medicine, biology.organism_classification, Antimicrobial, Enterobacteriaceae, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Infectious Diseases, Healthcare associated, [ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology, medicine, Pharmacology (medical), 030212 general & internal medicine, Intensive care medicine, business, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Community onset
Abstract: International audience
Published: 2017

23. Complications of dexamethasone prescribed for Streptococcus pneumoniae meningitis associated with cerebral vasculitis involving large- to medium-sized vessels

Author: A. Gouvion, A. Corchia, P. Raclot, Yohan Nguyen, S. Deguelte-Lardiere, V. Vernet Garnier, Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), and Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: 0301 basic medicine, Pathology, medicine.medical_specialty, medicine.medical_treatment, 030106 microbiology, Splenectomy, 03 medical and health sciences, X ray computed, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, medicine, Dexamethasone, ComputingMilieux_MISCELLANEOUS, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, medicine.disease, 3. Good health, Neurology, Immunology, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Neurology (clinical), Vasculitis, business, Meningitis, Cerebral vasculitis, medicine.drug, Streptococcus pneumoniae Meningitis
Abstract: International audience
Published: 2017

24. Deux infections opportunistes successives associées à une lymphopénie CD4 sévère révélant une sarcoïdose systémique

Author: Kévin Didier, Amélie Servettaz, Yohan Nguyen, Firouzé Bani-Sadr, and Thierry Tabary
Subjects: medicine.medical_specialty, business.industry, Systemic sarcoidosis, medicine, General Medicine, Lymphocytopenia, medicine.disease, business, Dermatology
Published: 2018

25. Time interval between infective endocarditis first symptoms and diagnosis: relationship to infective endocarditis characteristics, microorganisms and prognosis

Author: Xavier Duval, Bruno Hoen, Coralie Bouchiat, François Alla, Christine Selton-Suty, François Delahaye, Marie-Line Erpelding, Yohan Nguyen, Matthieu Saada, Matthieu Revest, Christophe Strady, Catherine Chirouze, Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Service de médecine interne [CHU Reims], CIC Hôpital Bichat, Institut National de la Santé et de la Recherche Médicale (INSERM)-UFR de Médecine-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service des maladies infectieuses et réanimation médicale [Rennes], Hôpital Pontchaillou-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Service des maladies infectieuses et tropicales [CH Perpignan 20], Centre Hospitalier Saint Jean de Perpignan, Centre d'investigation clinique - Epidémiologie clinique [Nancy] (CIC-EC), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Epidémiologie et Evaluations Cliniques [CHRU Nancy] (Pôle S2R), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de Cardiologie [CHRU Nancy], Centre National de Reference des Staphylocoques, Université de Lyon, Hôpital Louis Pradel [CHU - HCL], Hospices Civils de Lyon (HCL), Université Claude Bernard Lyon 1 (UCBL), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre d'Investigation Clinique - Innovation Technologique [Nancy] (CIC-IT), Maladies chroniques, santé perçue, et processus d'adaptation (APEMAC), Université de Lorraine (UL), Polyclinique Saint André, Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane), Université des Antilles et de la Guyane (UAG)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française], Université des Antilles - UFR des sciences médicales Hyacinthe Bastaraud (UA UFR SM), Université des Antilles (UA), Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], CHU Pontchaillou [Rennes], and CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Institut National de la Santé et de la Recherche Médicale (INSERM)-Université des Antilles et de la Guyane (UAG)
Subjects: Male, Time Factors, Valve surgery, [SDV]Life Sciences [q-bio], 030204 cardiovascular system & hematology, 0302 clinical medicine, Epidemiology, Hospital Mortality, Prospective Studies, 030212 general & internal medicine, Stroke, ComputingMilieux_MISCELLANEOUS, education.field_of_study, Endocarditis, Mortality rate, acute, General Medicine, Middle Aged, Staphylococcal Infections, Surgical Instruments, stroke, 3. Good health, Cardiac surgery, chronic, Heart Valve Prosthesis, Infective endocarditis, Female, France, cardiac surgery, Staphylococcus aureus, medicine.medical_specialty, Population, 03 medical and health sciences, Internal medicine, medicine, Humans, education, Aged, business.industry, Septic shock, Endocarditis, Bacterial, medicine.disease, mortality, Surgery, Early Diagnosis, septic shock, prognosis, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract: International audience; OBJECTIVE: To analyze the characteristics and outcome of infective endocarditis (IE) according to the time interval between IE first symptoms and diagnosis.METHODS: Among the IE cases of a French population-based epidemiological survey, patients having early-diagnosed IE (diagnosis of IE within 1 month of first symptoms) were compared with those having late-diagnosed IE (diagnosis of IE more than 1 month after first symptoms).RESULTS: Among the 486 definite-IE, 124 (25%) had late-diagnosed IE whereas others had early-diagnosed IE. Early-diagnosed IE were independently associated with female gender (OR = 1.8; 95% CI [1.0-3.0]), prosthetic valve (OR= 2.6; 95% CI [1.4-5.0]) and staphylococci as causative pathogen (OR = 3.7; 95% CI [2.2-6.2]). Cardiac surgery theoretical indication rates were not different between early and late-diagnosed IE (56.3% vs 58.9%), whereas valve surgery performance was lower in early-diagnosed IE (41% vs 53%; p = .03). In-hospital mortality rates were higher in early-diagnosed IE than in late-diagnosed IE (25.1% vs 16.1%; p
Published: 2016

26. Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues

Author: Yohan Nguyen, Damien Metz, Fanny Renois, Paul Fornes, Laurent Andreoletti, Firouzé Bani-Sadr, Alexis Bouin, Michel Wehbe, Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims), Université de Reims Champagne-Ardenne (URCA), and Centre Hospitalier Universitaire de Reims (CHU Reims)
Subjects: 0301 basic medicine, Epidemiology, viruses, [SDV]Life Sciences [q-bio], DNA Mutational Analysis, lcsh:Medicine, 5′ terminally deleted populations, medicine.disease_cause, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Medicine, Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues, ComputingMilieux_MISCELLANEOUS, Sequence Deletion, Endocarditis, enterovirus, Dispatch, Heart, Dilated cardiomyopathy, Middle Aged, endomyocardial, Enterovirus B, Human, 3. Good health, Infectious Diseases, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, RNA, Viral, coxsackievirus B3, Female, Microbiology (medical), Coxsackievirus Infections, Deep sequencing, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, Idiopathic dilated cardiomyopathy, Humans, lcsh:RC109-216, human, business.industry, Myocardium, lcsh:R, RNA, medicine.disease, Virology, idiopathic dilated cardiomyopathy, 030104 developmental biology, Nucleic acid, Enterovirus, business
Abstract: International audience; We performed deep sequencing analysis of the enterovirus 5′ noncoding region in cardiac biopsies from a patient with dilated cardiomyopathy. Results displayed a mix of deleted and full-length coxsackievirus B3, characterized by a low viral RNA load (8.10 2 copies/µg of nucleic acids) and a low viral RNA positive-sense to RNA negative-sense ratio of 4.8.
Published: 2016

27. No serological evidence for Borrelia burgdorferi sensu lato infection in patients with dilated cardiomyopathy in Northern France

Author: Damien Metz, Yohan Nguyen, François Lesaffre, Benoît Jaulhac, Laurent Andreoletti, Sylvie De Martino, Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Centre Hospitalier Universitaire de Reims (CHU Reims), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), and Les Hôpitaux Universitaires de Strasbourg (HUS)
Subjects: Male, serology, 030204 cardiovascular system & hematology, 0302 clinical medicine, Lyme disease, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, 030212 general & internal medicine, Stroke, ComputingMilieux_MISCELLANEOUS, Lyme Disease, Dilated Cardiomyopathy, biology, Dilated cardiomyopathy, General Medicine, Middle Aged, Antibodies, Bacterial, 3. Good health, Borrelia burgdoferi sensu lato, Infectious Diseases, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Female, France, Vasculitis, Adult, Cardiomyopathy, Dilated, Microbiology (medical), Enzyme-Linked Immunosorbent Assay, 03 medical and health sciences, Borrelia burgdorferi Group, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, medicine, Humans, Borrelia burgdorferi, Aged, General Immunology and Microbiology, business.industry, Endomyocardial Biopsy, bacterial infections and mycoses, medicine.disease, biology.organism_classification, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Review article, ceftriaxone, Immunoglobulin M, Immunoglobulin G, Immunology, biology.protein, Etiology, business
Abstract: Dear Editor,We read with interest a recent review article in the present journal in which evidence in favour of Borrelia burgdorferi as an aetiological agent of vasculitis and stroke was presented....
Published: 2016

28. Portal hypertension with extensive fibrosis and plasma cell infiltration in multiple myeloma

Author: Anthony Corchia, Aurélien Giltat, Raphael Cohen, Firouzé Bani-Sadr, Yohan Nguyen, Florent Ehrhard, Marie-Danièle Diebold, Bernard Pignon, and Camille Boulagnon
Subjects: 0301 basic medicine, Liver Cirrhosis, Pathology, medicine.medical_specialty, medicine.medical_treatment, Plasma Cells, 03 medical and health sciences, 0302 clinical medicine, Cholestasis, Fibrosis, Hypertension, Portal, medicine, Humans, Multiple myeloma, Aged, Chemotherapy, Hepatology, business.industry, Gastroenterology, medicine.disease, 030112 virology, Liver, Plasma cell infiltration, Immunoglobulin G, Etiology, Portal hypertension, Female, Liver dysfunction, business, Multiple Myeloma, 030215 immunology
Abstract: Plasma cell infiltration of the liver has been described in about 45% of patient with multiple myeloma in autopsy review; however, it is usually not associated with significant liver dysfunction. Indeed, only rare cases of massive plasma cell infiltration leading to non-obstructive cholestasis and hepatic failure have been described. Here, we report a case with a history of 8 years of MM with extensive liver fibrosis and portal hypertension with no other evidence aetiology unless massive plasma cell infiltration who presented a significant regression of both biological liver abnormalities and liver stiffness after ten months of chemotherapy concomitantly to a significant decrease of the IgG serum monoclonal band.
Published: 2016

29. Early neuropsychological adverse events after switching from PI/r to dolutegravir could be related to hyperthyroidism in patients under levothyroxine

Author: Jean-Luc Berger, Firouzé Bani-Sadr, M. Hentzien, Yohan Nguyen, Caroline Migault, Hélène Marty, Delphine Lebrun, Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), and Laboratoire de Pharmacologie et Toxicologie [CHU Reims]
Subjects: Male, endocrine system, Anti-HIV Agents, Pyridones, viruses, Levothyroxine, Glucuronidation, HIV Infections, Neuropsychological Tests, 030204 cardiovascular system & hematology, Pharmacology, Hyperthyroidism, Piperazines, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Thyroid-stimulating hormone, immune system diseases, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Antiretroviral Therapy, Highly Active, Oxazines, medicine, Humans, Drug Interactions, Pharmacology (medical), In patient, Adverse effect, ComputingMilieux_MISCELLANEOUS, Aged, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, Ritonavir, Drug Substitution, business.industry, Neuropsychology, virus diseases, HIV Protease Inhibitors, biochemical phenomena, metabolism, and nutrition, 3. Good health, Thyroxine, Infectious Diseases, chemistry, 030220 oncology & carcinogenesis, Dolutegravir, Female, business, Heterocyclic Compounds, 3-Ring, medicine.drug
Abstract: We report two patients who had taken levothyroxine at the same dose for several years and who had stable thyroid stimulating hormone (TSH) levels, and who developed clinical and biological hyperthyroidism following switch from ritonavir-boosted protease inhibitors (PIs) to dolutegravir-based HAART. Levothyroxine is metabolized by deiodination and glucuronidation and the induction of glucuronidation by ritonavir leads to an increased elimination of levothyroxine and a necessity of higher daily doses. Patients who switch from ritonavir-boosted PIs to antiretroviral drugs-based HAART with minimal drug-interaction such as dolutegravir, may require an adjustment in their dose of levothyroxine in order to prevent hyperthyroidism due to impaired elimination of levothyroxine without ritonavir.
Published: 2016

30. Pneumopathies sévères sous idelalisib : ne pas méconnaître la toxicité pulmonaire médicamenteuse

Author: Alain Delmer, D. Toubas, Firouzé Bani-Sadr, Yohan Nguyen, Aurélien Giltat, Caroline Migault, G. Julien, O. Toubas, F. Lebargy, and D. Lebrun
Subjects: Infectious Diseases
Abstract: Introduction L’idelalisib est le premier medicament d’une nouvelle classe de therapie ciblee. Il s’agit d’un inhibiteur des PI3 kinase, indique en association avec le rituximab dans le traitement de patients atteints de leucemie lymphoide chronique et de lymphome folliculaire. Des pneumopathies severes ont ete decrites au cours d’essais therapeutiques avec une surmortalite dans le bras idelalisib. Materiels et methodes Nous rapportons une serie de 5 cas de pneumopathies severes parmi les 16 patients (31 %) ayant initie l’idelalisib entre septembre 2014 et novembre 2015 dans notre centre. Resultats Le delai median etait de 1 mois (extremes, 1–11). Un patient a presente une pneumopathie a P. jiroveci et 1 patient une pneumopathie au decours d’une neutropenie severe. Dans les 3 autres cas, aucune etiologie infectieuse n’a pu etre mise en evidence malgre un bilan exhaustif (lavage broncho-alveolaire). Dans ces cas, l’arret de l’idelalisib et la corticotherapie a ete suivi d’une evolution favorable. Les pneumopathies sous idelalisib peuvent etre secondaires a des pneumonies infectieuses ou a une toxicite pulmonaire medicamenteuse. La physiopathogenie de cette toxicite n’est pas connue mais s’apparente a celle deja decrite avec les inhibiteurs de mTOR ; l’idelalisib en inhibant PI3Kδ inhibe aussi la voie des mTOR. Conclusion Les infectiologues ne doivent pas meconnaitre la toxicite medicamenteuse pulmonaire dans l’approche diagnostique d’une pneumopathie survenant chez un patient traite par idelalisib.
Published: 2017

31. Évaluation de la présentation clinique, des modes de contamination et de l’évolution des cas de tularémie en Champagne-Ardenne (Nord-Est de la France)

Author: T. Malissart, T. Guillard, J.M. Galempoix, K. Didier, Yohan Nguyen, Firouzé Bani-Sadr, V. Laurent-Noel, Roland Jaussaud, and Amélie Servettaz
Subjects: Gastroenterology, Internal Medicine
Abstract: Introduction La tularemie est une zoonose aux modes de contaminations multiples et responsable de formes cliniques variees. Nos objectifs etaient d’evaluer les formes cliniques, les moyens diagnostiques, les traitements et l’evolution des cas de tularemie dans une region particulierement exposee a cette maladie. Patients et methodes Etude epidemiologique descriptive retrospective en Champagne-Ardenne entre 2005 et 2015. Resultats Dix-huit cas sporadiques de tularemie ont ete etudies, touchant une population majoritairement rurale. La majorite des formes cliniques etaient des formes ulcero-ganglionnaires et ganglionnaires. L’origine de la contamination la plus frequente etait la manipulation du gibier (6/18 cas) et notamment de lievre (5/18 cas). Un seul cas etait attribue a une morsure de tique. Au total, 9/18 patients, non-immunodeprimes, ont presente au moins une complication a type de suppuration d’adenopathie (4/18) et/ou de persistance d’une adenopathie au-dela de 3 mois (3/18). Conclusion La tularemie reste meconnue, source d’errance diagnostique. Dans cette serie, la contamination est le plus frequemment due a la manipulation d’un animal sauvage contamine, et la maladie se presente le plus souvent sous une forme ulcero-ganglionnaire et ganglionnaire. Cette affection, consideree comme benigne hormis dans ses formes systemiques, rares, et chez les patients immunodeprimes peut etre responsable de complications parfois durables chez des patients jeunes et immunocompetents.
Published: 2017

32. Severe apoptotic enteropathy caused by methotrexate treatment for rheumatoid arthritis

Author: Yohan Nguyen, Ségolène Toquet, Camille Boulagnon, Zoubir Djerada, Firouzé Bani-Sadr, and Adel Sabbagh
Subjects: Adult, Diarrhea, Male, medicine.medical_specialty, Biopsy, Apoptosis, Gastroenterology, Arthritis, Rheumatoid, 03 medical and health sciences, Basal (phylogenetics), 0302 clinical medicine, Rheumatology, Intestinal mucosa, Internal medicine, medicine, Humans, Enteropathy, Colitis, Intestinal Mucosa, medicine.diagnostic_test, business.industry, medicine.disease, digestive system diseases, Methotrexate, 030220 oncology & carcinogenesis, Rheumatoid arthritis, Antirheumatic Agents, medicine.symptom, business, 030217 neurology & neurosurgery, medicine.drug
Abstract: The folic acid antagonist methotrexate is a cornerstone treatment of rheumatoid arthritis. Its use is limited chiefly by gastrointestinal toxicity, which is among the main reasons for methotrexate discontinuation. Here, we report the case of a 40-year-old man on chronic methotrexate therapy in whom life-threatening apoptotic enteropathy with watery diarrhea and hypovolemic shock developed after he was switched from the oral to the intramuscular route, with no change in dosage. Colonic biopsies suggested drug-induced colitis, showing a nonspecific, mildly inflammatory infiltrate of lymphocytes and plasma cells, dilated damaged crypts, and a marked increase in basal crypt apoptosis (>20 apoptotic bodies/100 crypts). Clinicians should be aware that methotrexate can cause life-threatening apoptotic enteropathy. Increased basal crypt apoptosis in colonic biopsies with more than 5 apoptotic bodies/100 crypts should routinely suggest drug-induced enteropathy.
Published: 2015

33. Des calcifications cardiaques

Author: A. Robbins, Firouzé Bani-Sadr, A. Colosio, Yohan Nguyen, D. Lambert, M. Hentzien, D. Lebrun, Complexe de recherche interprofessionnel en aérothermochimie (CORIA), Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Laboratoire d'aérologie (LAERO), Centre National de la Recherche Scientifique (CNRS)-Observatoire Midi-Pyrénées (OMP), Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Météo France-Centre National d'Études Spatiales [Toulouse] (CNES)-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées
Subjects: medicine.medical_specialty, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, business.industry, Gastroenterology, medicine.anatomical_structure, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Internal medicine, Mitral valve, Internal Medicine, medicine, Cardiology, Mitral annulus, business, ComputingMilieux_MISCELLANEOUS
Abstract: International audience
Published: 2015

34. Macroscopic amoxicillin crystalluria

Author: Anne Limelette, Maxime Hentzien, Firouzé Bani-Sadr, Delphine Lebrun, Dorothée Lambert, Roland Jaussaud, Ailsa Robbins, Yohan Nguyen, Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Centre Hospitalier Universitaire de Reims (CHU Reims), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), and Université Pierre et Marie Curie - Paris 6 (UPMC)
Subjects: medicine.medical_specialty, medicine.medical_treatment, [SDV]Life Sciences [q-bio], 030232 urology & nephrology, Renal function, Context (language use), Asymptomatic, Gastroenterology, Streptococcus agalactiae, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Oliguria, Streptococcal Infections, Internal medicine, medicine, Crystalluria, Humans, Renal replacement therapy, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, 0303 health sciences, 030306 microbiology, business.industry, Amoxicillin, Endocarditis, Bacterial, General Medicine, Acute Kidney Injury, Middle Aged, medicine.disease, 3. Good health, Female, medicine.symptom, Crystallization, Urinary tract obstruction, business, medicine.drug
Abstract: A 62-year-old woman was referred to our hospital in September, 2013, with fever, arthralgia, and dyspnoea lasting for 6 days. Her medical history was uneventful apart from hypertension and active tobacco use. Her glomerular fi ltration rate at admission was 82 mL/min per 1·73 m2 (normal range ≥90 mL/min per 1·73 m2). Blood cultures on admission grew Strepto coccus agalactiae and acute aortic infective endocarditis was rapidly diagnosed with transoesophageal echocardiography. She was immediately started on highdose intravenous amoxicillin (200 mg/kg per day) with intravenous gentamicin (240 mg once-daily). After 4 days, we noticed cloudy urine, with a thin granular appearance (fi gure). Her urine pH was 5·5. Direct examination of the urine showed amoxicillin crystalluria with large, typically aggregated needle-shaped crystals (fi gure) that were birefringent under polarised light microscopy. Her clinical condition worsened with oliguria, acute renal failure, and pulmonary oedema within 24 h. An aortic ring abscess was evident on a second echocardiography. After emergency valve replacement surgery and renal replacement therapy, she recovered well and was discharged home in October, 2013, without further renal replacement therapy, and with improving renal function. Her last glomerular fi ltration rate was 45 mL/min per 1·73 m2 in March, 2014. At last follow-up, in September, 2014, the patient was asymptomatic. Amoxicillin is known to cause urine crystallisation, although its incidence is unknown. Amoxicillin crystalluria usually occurs with high-dose amoxicillin therapy, in urines that have a low pH and are highdensity (mainly due to insuffi cient fl uid intakes). Amoxicillin crystalluria can be microscopic or macroscopic. The typical microscopic appearance described here is usually suffi cient for diagnosis in a compatible context but the amoxicillin composition of these crystals can be confi rmed by infrared spectroscopy if needed. Amoxicillin crystalluria can be asymptomatic or can be responsible for haematuria or acute renal failure attributable to intratubular precipitation or urinary tract obstruction. In our patient, acute renal failure was multifactorial, but we speculate that amoxicillin crystalluria could have played a part. Physicians should be aware of such a complication of amoxicillin because high intravenous doses are frequently prescribed worldwide and because urine alkalinisation and increased fl uid intake might prevent crystalluria.
Published: 2015

35. High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France

Author: Firouzé Bani-Sadr, Dorothée Lambert, Maxime Hentzien, Jean Luc Berger, Laurent Andreoletti, Roland Jaussaud, Delphine Lebrun, Isabelle Kmiec, Yohan Nguyen, Véronique Brodard, Christine Rouger, Moustapha Dramé, Centre Hospitalier Universitaire de Reims (CHU Reims), Laboratoire de Virologie Médicale et Moléculaire - EA 4684 (CardioVir), Université de Reims Champagne-Ardenne (URCA)-Centre Hospitalier Universitaire de Reims (CHU Reims)-SFR CAP Santé (Champagne-Ardenne Picardie Santé), Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV)-Université de Reims Champagne-Ardenne (URCA)-Université de Picardie Jules Verne (UPJV), Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Médecine interne, maladies infectieuses, immunologie clinique, Hôpital Robert Debré-Centre Hospitalier Universitaire de Reims (CHU Reims), Université Pierre et Marie Curie - Paris 6 (UPMC), and Université de Reims Champagne-Ardenne (URCA)-Université de Reims Champagne-Ardenne (URCA)
Subjects: Adult, Male, Pediatrics, medicine.medical_specialty, Immunology, HIV Infections, Antibodies, Viral, Measles, Risk Factors, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, medicine, Odds Ratio, Prevalence, Immunology and Allergy, Humans, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, High prevalence, biology, business.industry, Vaccination, Odds ratio, Middle Aged, medicine.disease, Confidence interval, 3. Good health, CD4 Lymphocyte Count, Immunity, Humoral, Infectious Diseases, Cohort, Humoral immunity, biology.protein, HIV-1, Female, France, Antibody, business
Abstract: We investigated measles humoral immunity levels in a cohort of HIV-infected adult patients in France and attempted to identify risk factors for antimeasles antibodies seronegativity. Being born after 1983 [odds ratio (OR) 4.40; 95% confidence interval (95% CI) 1.26-14.09; P = 0.0013] and a nadir CD4⁺ cell count below 100 cells/μl (OR 4.79; 95% CI 1.61-14.82; P = 0.0048) were the two factors independently associated with measles seronegativity. Systematic measles antibody screening should be performed in HIV-infected individuals born in the era of measles vaccination (after 1983 in France).
Published: 2015

36. Facteurs pronostiques associés à la mortalité intra-hospitalière sur 30 jours lors des bactériémies à staphylocoques à coagulase négative : absence d’impact de la concentration minimale inhibitrice à la vancomycine

Author: Amélie Servettaz, Firouzé Bani-Sadr, Christophe Strady, Véronique Vernet-Garnier, Alain Delmer, Yohan Nguyen, M. Hentzien, and C. De Champs
Subjects: Infectious Diseases
Abstract: Introduction Au cours des bacteriemies a staphylocoques coagulase-negatifs (SCN), l’impact d’une concentration minimale inhibitrice (CMI) a la vancomycine superieure ou egale a 2 mg/l sur la mortalite ainsi que le potentiel benefice des nouveaux antibiotiques antistaphylococciques sont inconnus. Nous avons etudie l’impact de la CMI a la vancomycine sur la mortalite intra-hospitaliere sur 30 jours et recherche les facteurs independamment associes a cette mortalite au cours des bacteriemies a SCN. Materiels et methodes Tous les patients ayant presente une bacteriemie significative a SCN entre le 01/01/2008 et le 31/12/2012 ont ete inclus. Les donnees ont ete retrospectivement extraites des dossiers medicaux des patients. La CMI a la vancomycine a ete mesuree par methode E-test et la recherche de resistance aux antibiotiques a ete realisee en accord avec les recommandations du comite de l’antibiogramme de la societe francaise de microbiologie. Un modele a risques proportionnels de Cox etait utilise pour l’analyse multivariee. Resultats Deux cent soixante-neuf patients (âge moyen 61,2 ± 15,7 ans) ont ete inclus. La presence de materiel etranger etait retrouvee chez 92 % (247/269) des patients, et 78 % (127/188) des souches isolees resistantes a la meticilline avaient egalement une CMI a la vancomycine ≥2 mg/l. La mortalite intra-hospitaliere sur 30 jours etait de 16 % (41/268). On ne retrouvait pas d’association entre une CMI a la vancomycine ≥2 mg/l et la mortalite (Hazard Ratio ajuste (HRa) = 0,90 ; intervalle de confiance a 95 % (IC95 %) [0,30–2,19] ; p = 0,67). Les facteurs independamment associes a la mortalite etaient un âge ≥ 75 vs ≤ 60 ans (HRa = 3,72 ; IC95 %[1,39–9,97] ; p = 0,009), l’absence d’antibiotherapie active sur la souche isolee (HRa = 5,52 ; IC95 %[1,13–26,87], p = 0,03) et l’insuffisance renale aigue (HRa = 4,45 ; IC95 %[2,08–9,56] ; p = 0,0001). L’ablation de materiel infecte etait un facteur protecteur (HRa = 0,23 ; IC95 %[0,11–0,48] ; p Conclusion Ces donnees suggerent que les bacteriemies a SCN devraient etre traitees en premier lieu par l’ablation du materiel infecte et par une antibiotherapie telle que la vancomycine, independamment de la CMI a la vancomycine.
Published: 2017

37. Poor knowledge among French travellers of the risk of acquiring multidrug-resistant bacteria during travel

Author: Maxime Hentzien, Yohan Nguyen, Firouzé Bani-Sadr, Aurélien Giltat, Caroline Migault, Moustapha Dramé, Lukshe Kanagaratnam, Delphine Lebrun, Odile Bajolet, Centre Hospitalier Universitaire de Reims (CHU Reims), Service de Médecine interne, Maladies Infectieuses et Immunologie Clinique [Reims], Institut Français de Recherche en Afrique / French Institute for Research in Africa (IFRA / FIRA Nairobi), Ministère de l'Europe et des Affaires étrangères (MEAE)-Centre National de la Recherche Scientifique (CNRS), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Dynamique cellulaire et moléculaire de la muqueuse respiratoire, and Université de Reims Champagne-Ardenne (URCA)-IFR53-Institut National de la Santé et de la Recherche Médicale (INSERM)
Subjects: Adult, Male, 0301 basic medicine, Health Knowledge, Attitudes, Practice, medicine.medical_specialty, South asia, [SDV]Life Sciences [q-bio], MESH: Health Knowledge, Attitudes, Practice, 030106 microbiology, Routine practice, 03 medical and health sciences, Antibiotic resistance, international travel, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Resistance, Multiple, Bacterial, Surveys and Questionnaires, Environmental health, Humans, Medicine, Travel medicine, travellers’, MESH: Surveys and Questionnaires, Risk factor, Antibiotic use, MESH: Travel, ComputingMilieux_MISCELLANEOUS, Travel, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, MESH: Humans, MESH: Middle Aged, business.industry, MESH: Adult, MESH: Drug Resistance, Multiple, Bacterial, General Medicine, Middle Aged, MESH: Male, 3. Good health, Surgery, diarrhoea, MESH: France, Multidrug-resistant Enterobacteriaceae acquisition, Multidrug resistant bacteria, ESBL, Community setting, Female, France, business, MESH: Female
Abstract: Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug-resistant Enterobacteriaceae (MRE) during international travel, we aimed to determine, among French travellers attending a consultation for travel medicine, their level of knowledge about the risk of acquiring MRE. Among 191 adults enrolled in the study, only 10% of travellers were aware of the risk of becoming a carrier of MRE during travel, and 87% did not understand the difference between being colonized with MRE, and having a clinical infection with MRE. Consultations for travel medicine could be an opportunity to deliver specific information about the risks of acquiring MRE. Antibiotic resistance among Gram-negative bacteria is an emerging problem worldwide, mainly with the diffusion of extended spectrum beta-lactamase, plasmid-encoded cephalosporinases and carbapenemases-producing Enterobacteriaceae. These strains often show multi-resistance and are now diffusing worldwide in the community setting, outside of the hospital. Travel in areas endemic for multidrug-resistant Enterobacteriaceae (MRE) has been identified as a risk factor for the acquisition of MRE.1–5 Faecal colonization with MRE is very frequent among travellers to tropical regions, with a risk ranging from 20 to 70%, especially among those visiting the South Asian continent.2,3,5 Moreover, antibiotic use could favour proliferation of MRE by disrupting the intestinal microbiota balance, and the use of antibiotics for travel diarrhoea was associated with a 4-fold increase in the risk of acquiring MRE, whereas travel diarrhoea itself was only associated with a 2-fold increase in risk.2,3,6 Taken together, these elements suggest that informing the public about the risk of acquiring MRE during international travel could represent a preventive measure against the spread of MRE in France. The French public has been made aware of multidrug-resistant (MDR) bacteria through a media campaign conducted …
Published: 2016

38. High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France.

Author: Lambert, Dorothee, Dramé, Moustapha, Rouger, Christine, Brodard, Veronique, Yohan Nguyen, Berger, Jean Luc, Kmiec, Isabelle, Hentzien, Maxime, Lebrun, Delphine, Jaussaud, Roland, Andreoletti, Laurent, and Bani-Sadr, Firouzé
Published: 2015
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Database

Publisher

38 results on '"Yohan Nguyen"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources